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ABSTRACT 
 
Soumya Vemuganti:  Novel Sperm-Specific Glycolytic Isozymes Generated by 
Retrotransposition and Alternative Splicing 
 
 (Under the direction of Dr. Deborah A. O’Brien) 
 
 
Targeted gene disruption of glycolytic enzymes expressed only during 
spermatogenesis indicates that glycolysis is essential for sperm motility and male fertility.  
This pathway is compartmentalized in the principal piece of the sperm flagellum, where 
several spermatogenic cell-specific isozymes are bound to a cytoskeletal structure known as 
the fibrous sheath.  Fructose-1,6-bisphosphate aldolase, or aldolase, is the fourth enzyme in 
the glycolytic pathway.  Genomic and proteomic analyses identified three aldolase A (Aldoa) 
transcripts generated by retrotransposition and alternative splicing:  Aldoa_v2, Aldoart1, and 
Aldoart2.  Unique nucleotide sequence in Aldoart1 provided evidence for an alternatively 
spliced exon in Aldoa_v2.  Expression of all three isozymes was restricted to the male 
germline and was regulated at transcriptional and translational levels.  Both ALDOART1 and 
ALDOA_V2 are tightly bound to the fibrous sheath and have unique N-terminal extensions 
that may mediate this binding.  ALDOA_V2 is conserved across species and is expressed in 
rat and human sperm.  Preliminary modeling data predicted unique amino acids near 
functional domains in each isozyme, suggesting distinctive binding and/or catalytic 
properties.  Recombinant sperm ALDOA-related isozymes demonstrated reduced activity 
when expressed in E. coli, perhaps due to difficulties producing proteins with native 
conformations.  However, analysis of aldolase kinetic parameters in mouse sperm identified 
a significant portion of the total activity in insoluble fractions, providing initial evidence that 
the novel ALDOA-related isozymes bound to the fibrous sheath are active.   
 iii 
Glycolytic enzymes with restricted expression during spermatogenesis arose via 
gene duplication (Gapdhs) and retrotransposition (Pgk2, Aldoart1, Aldoart2).  A genomic 
approach identified all retroposed sequences matching glycolytic enzymes in the human and 
mouse genomes.  Each glycolytic enzyme is encoded by a family of genes, and there is 
frequent retrotransposition of a single gene in each family.  The same orthologous gene is 
independently retroposed in both species.  Results from this study identified an alternative 
form of Gpi1 transcribed during mouse spermatogenesis.  Annotation and expression 
analysis of all glycolytic enzymes expressed during spermatogenesis will help to understand 
the regulation of energy metabolism.  Since glycolysis is required for sperm motility and 
male fertility, spermatogenic-cell specific glycolytic enzymes are potential targets for 
contraceptives.  Determining whether defects in the glycolytic pathway are a significant 
cause of male infertility is also an important clinical need.   
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CHAPTER I 
INTRODUCTION 
 
Sperm motility is essential for fertilization. 
Fertilization is a complex process dependent upon the proper completion of many 
events, including the delivery of the male genome in sperm to the egg.  Before binding and 
penetrating the egg, sperm must travel through the female reproductive tract to the site of 
fertilization in the oviduct and penetrate the zona pellucida of the egg [1, 2].  Both motility 
and hyperactivated motility of sperm are essential for penetration of the zona pellucida and 
fertilization [3].   
Rapid movement of sperm is propagated by the flagellum, a complex structure that is 
conserved across species and cell types [4].  The sperm flagellum consists of a connecting 
piece, middle piece, principal piece, and end piece (Figure 1.1).   A “9+2” axoneme structure 
extends from the distal centriole reminant throughout the length of the flagellum [5].  The 
axoneme contains nine outer microtubule doublets and a central pair of microtubules.  Each 
outer microtubule double is attached to the adjacent doublet and possesses dynein arms, 
which function as the motor of the sperm flagellum and facilitate movement.  Dynein 
ATPases are localized along the entire sperm flagellum and are activated during sperm 
movement, resulting in sliding between adjacent outer microtubule doublets [4].   
Axoneme structure is conserved in all cilia and flagella, but mammalian sperm 
flagella contain two accessory structures not found in other flagella:  outer dense fibers and 
the fibrous sheath [4].  Nine outer dense fibers (ODFs) surround the outer microtubule 
doublets in the middle piece.  The mitochondria are localized in the middle piece and are 
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arranged as a sheath structure encompassing the axoneme and ODFs.  In the principal 
piece two ODFs (3 and 8) are replaced by the longitudinal columns of the fibrous sheath.  
The fibrous sheath, an insoluble cytoskeletal structure which defines the principal piece, 
consists of two longitudinal columns and connecting transverse ribs.  Both the ODFs and 
fibrous sheath are thought to contribute to the rigid structure of the sperm flagellum, which 
helps to regulate movement along with activation of dynein ATPases associated with the 
microtubule doublets [5, 6].     
Novel contraceptive approaches can target and inhibit sperm motility, thereby 
preventing zona pellucida penetration and fertilization.  Most current contraceptive methods 
are hormonal and taken by women.  Hormonal contraceptives are effective but carry with 
them undesirable side effects [7].  A non-hormonal male contraceptive that targets 
molecules found only in sperm would have fewer side effects.  Therefore, proteins essential 
for sperm motility and expressed only during spermatogenesis are potential male 
contraceptive targets.   
   Conversely, impaired sperm motility can lead to male infertility [6, 8].  One study from 
1085 patients with male factor infertility concluded that approximately 81% had defects in 
sperm motility, with 19% having no other defects in sperm morphology or count [9].  
Proteomic profiling of sperm from 20 patients with defects in sperm motility compared to 
control donors showed differential expression of proteins localized to the flagellum, including 
cytoskeletal β-actin, ACTB [10].  In fact, multiple studies have identified mutations in genes 
encoding flagellar proteins in patients with low sperm motility.  This includes mutations in 
dynein proteins, resulting in primary ciliary dyskinesia; tektin-t, an axonemal protein resulting 
in ultrastructural defects in the sperm tail; and AKAP3/AKAP4 deletions resulting in 
malformation (dysplasia) of the fibrous sheath and short tails [11-13].  Taken together, 
mutations in several genes encoding proteins localized to the sperm flagellum lead to 
decreased sperm motility and male infertility.     
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Glucose is required for hyperactivated motility and fertilization. 
Spermatogenesis is the process by which germline stem cells differentiate into 
spermatozoa and can be divided into three phases:  a proliferative mitotic phase that serves 
to increase cell number (spermatogonia), a meiotic phase when recombination occurs and 
number of chromosome sets are reduced (spermatocytes), and a haploid differentiation 
phase (spermiogenesis) producing highly specialized cells (round spermatids, condensing 
spermatids, and spermatozoa).   
Cellular components are reorganized during spermiogenesis.  Most of the cytoplasm 
is lost, the nucleus is condensed in the head, the acrosome forms and the flagellum forms.  
The flagellum contains the energy production system and machinery required for motility.  
The mitochondria are stacked into the middle piece of the flagellum and the glycolytic 
enzymes are localized to the principal piece (Figure 1.1).  Therefore, ATP-generating 
metabolic pathways are compartmentalized in sperm, with oxidative phosphorylation 
occurring in the middle piece and glycolysis localized to the principal piece of the tail (Figure 
1.1).  Glycolysis converts glucose into two pyruvate molecules, with a net production of two 
ATP per glucose molecule (Figure 1.2).  Pyruvate that is produced during glycolysis can be 
further metabolized in the mitochondria via the Krebs cycle and oxidative phosphorylation, 
or alternatively, converted to lactate in the cytoplasm.    
Dynein ATPases located along the entire flagellum require ATP for sperm 
movement.  It was originally thought that ATP produced via oxidative phosphorylation in the 
mitochondria was shuttled to the principal piece.  However, blocking mitochondrial ATP 
production in mouse sperm by the use of the inhibitors oligomycin or carbonyl cyanide m-
chlorophenylhydrazone (CCCP), or by targeted gene disruption of testis-specific cytochrome 
c (cyt ct,) demonstrate that oxidative phosphorylation is not required for motility and 
fertilization [3, 14, 15].  Together these results indicate that ATP generated via glycolysis is 
 4
required for sperm motility and fertilization in the mouse.  The role of glycolysis in human 
sperm ATP production and motility is still unclear since inhibitors of both glycolysis and 
oxidative phosphorylation reduced ATP levels and motility [16-18].  Contradictory results 
suggest that human sperm motility is supported by substrates metabolized by oxidative 
phosphorylation, as well as glycolysable substrates [18-21].   It is clear that there are 
species differences in terms of the glycolytic and oxidative capacity of sperm.  Two potential 
substrates of the glycolytic pathway include glucose and fructose.      
Glucose is metabolized by hexokinase at the beginning of the glycolytic pathway 
(Figure 1.2).  In vitro fertilization studies in mouse demonstrated that exogenous glucose, 
but not lactate or pyruvate, support hyperactivated sperm motility [3, 22, 23].  Similar studies 
using purified populations of human sperm without exogenous glucose resulted in a 
decrease in overall motility, a lack of hyperactivated motility, and reduced zona penetration 
[18, 24, 25].   
Fructose can be metabolized either by hexokinase at the beginning of the glycolytic 
pathway (Figure 1.2), or by an aldolase-dependent three-step reaction (Figure 1.3).  
Hexokinase has a higher affinity for glucose than fructose, but will still bind and 
phosphorylate fructose [26].  Fructose-1,6-bisphosphate aldolase, or aldolase, is the fourth 
enzyme in the glycolytic pathway (Figure 1.2).  When fructose is metabolized through an 
aldolase-dependent pathway, the cleavage product re-enters the glycolytic pathway as 
glyceraldehyde-3-phosphate, the substrate of glyceraldehyde-phosphate dehydrogenase 
(GAPDH).  One of the enzymes required for aldolase-dependent metabolism of fructose 
(ketohexokinase) is expressed at low levels in mouse testis, while the there is no evidence 
for expression of the other enzyme (triose kinase) in testis or in sperm [27].   
Fructose is metabolized by mouse sperm in vitro, but sperm exhibit sluggish motility 
after 6 hours of incubation [3, 28].  In human sperm, high levels of fructose in seminal 
plasma (0.016M in 108/ml sperm) are sufficient to support glycolytic ATP production [26].  
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Sperm from both normal and oligospermic patients metabolize fructose at the same rate, 
while sperm from necrospermic patients demonstrate lower levels of fructolysis [29].  Also, 
men with no sperm in their seminal plasma (nonobstructive azoospermia) have higher 
fructose levels in their semen, possibly due to a lack of sperm consuming the substrate [30].   
Multiple hexose transporters, or glucose transporters (GLUTs), facilitate the entry of 
glucose and fructose into sperm for metabolism and are localized along the sperm 
membrane.  GLUT3, the most abundant transporter, is found in both mouse and human 
sperm and has a high affinity for glucose [31, 32].  GLUT8, 9a, and 9b facilitate glucose 
transport in mouse sperm and testis, with each isoform demonstrating unique localization in 
sperm [33].  Only one transporter, GLUT5, has a high affinity for fructose and has been 
detected in human sperm [34].   
Taken together, it is clear that glucose is metabolized by mouse sperm and supports 
motility required for fertilization [3].  Fructose is also metabolized by mouse sperm, resulting 
in slower motility which does not support all of the events required for fertilization [3, 22, 28].  
In human sperm, both glucose and fructose support motility and high ATP levels [18].  There 
is a great deal of evidence supporting a critical role for glucose with in vitro fertilization using 
human sperm, but the role of fructose has not been analyzed as extensively [18, 24, 25].    
 
Spermatogenic cell-specific glycolytic enzymes are required for sperm motility and 
fertilization.   
The glycolytic pathway is modified substantially in mammalian sperm and includes 
multiple isozymes with novel structural or enzymatic properties.  Glyceraldehyde 3-
phosphate dehydrogenase-S (GAPDHS), phosphoglycerate kinase-2 (PGK2), and lactate 
dehydrogenase-C (LDHC) are three glycolytic isozymes encoded by genes expressed only 
during spermatogenesis [35-37].  The gene encoding GAPDHS was first identified through 
screening of a mouse spermatogenic cell expression library, and Gapdhs expression is first 
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detected in haploid cells [37, 38].  Pgk2 is a well-characterized retrogene that is first 
expressed during meiotic prophase, although translation of the Pgk2 transcript is delayed 
until spermiogenesis [35, 39-42].  Ldhc (formerly Ldh-x) is first transcribed in preleptotene 
spermatocytes, coinciding with the detection of LDHC activity [43-45].   
 Mechanisms of gene creation include retrotransposition and gene duplication.  
Spermatogenic-cell specific isozymes in the glycolytic pathway provide examples of both 
mechanisms.  Gene duplication is responsible for Gapdhs and Ldhc, while Pgk2 was 
retroposed from the X-linked, ubiquitously expressed Pgk1 [35, 38, 39, 46].  Other examples 
of testis-specific retrogenes include, polyA binding protein 2, pyruvate dehydrogenase E1α2, 
TATA-binding protein and associated factor TAFII250, and glucose-6-phosphate 
dehydrogenase [47-50].   
Other glycolytic enzymes with restricted expression during spermatogenesis exhibit 
modified structures and/or functions, including hexokinase-1 (HK1), glucose phosphate 
isomerase (GPI), triose phosphate isomerase (TPI), phosphoglycerate mutase (PGAM), and 
enolase (ENO) [51-55].  Three splice variants of Hk1 expressed during spermatogenesis 
possess unique 5’ sequence encoding a sperm-specific region (SSR) [54, 56].  A unique 
species of GPI  in mouse testis and sperm was detected by cellulose acetate 
electrophoresis coupled with glucose phosphate isomerase activity staining  [51].  In rat, a 
larger Tpi transcript is expressed in haploid cells during spermatogenesis [55].  Sperm-
specific forms of ENO were detected using cellulose acetate electrophoresis and activity 
staining [52, 57].  Modification of the glycolytic pathway through the expression of novel 
isozymes, combined with the requirement of glucose for sperm motility, highlights an 
essential role for proper regulation of glycolysis in sperm. 
Sperm motility is dependent upon the production of high levels of ATP in the 
flagellum [15, 18, 26].  Glycolysis, rather than oxidative phosphorylation, is required for 
sperm motility and male fertility in mice [14, 58].  Early studies developing reversible 
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contraceptives identified chlorinated compounds as inhibitors of GAPDHS function, resulting 
in reduced glycolysis and motility [59].  Targeted disruption of Gapdhs resulted in marked 
reduction in ATP levels, the absence of progressive sperm motility and male infertility in 
mice [58].  Disruption of the genes for Pgk2 and Ldhc  produced sperm with lower ATP 
levels and reduced motility [60, 61].  Gene disruption and inhibitor studies collectively 
demonstrate a critical role for spermatogenic-specific glycolytic enzymes in male fertility. 
 
Many sperm-specific glycolytic enzymes are tightly bound to the fibrous sheath. 
Enzymes in the glycolytic pathway are localized to the principal piece of the sperm 
flagellum and several are tightly bound to the fibrous sheath, a cytoskeletal structure that 
defines the limits of the principal piece (Figure 1.1).  Glycolytic enzymes resistant to urea 
extraction and tightly bound to the fibrous sheath include GAPDHS, aldolase A (ALDOA), 
and LDHA [62].  Localization of glycolytic enzymes provides ATP production along the 
length of the principal piece, which makes up approximately 2/3 of the entire tail [4].  A 
similar pattern of localization is seen in the green algae Chlamydomonas reinhardtii, where 
multiple glycolytic enzymes are targeted to the flagellar compartment [63, 64].  Here, as in 
sperm, ATP is supplied along the length of the flagellum through glycolysis.  
Tight binding of glycolytic enzymes to the fibrous sheath suggests the formation of a 
multi-enzyme complex, which may result in higher catalytic activity.  Such complexes exist in 
nature (DNA processing, RNA/protein synthesis, pyruvate dehydrogenase complex, and the 
electron transport chain), and direct binding between glycolytic enzymes has been 
suggested [65-67].  One example includes localized glycolytic ATP production in the 
Drosophila flight muscle [68, 69].  In flies lacking glycerol-3-phosphate dehydrogenase, 
localization of ALDOA and GAPDH to the Z-discs and M-lines is lost, along with the ability to 
fly, supporting a correlation between localization and function [68, 69].  It is possible that the 
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close nature of glycolytic enzymes in the sperm flagellum may help “shuttle” substrates 
through the pathway in a more efficient manner.   
The most abundant proteins in the fibrous sheath are cAMP-dependent protein 
kinase anchoring proteins, or AKAPs [6].  AKAPs serve as a scaffold to anchor proteins to 
the fibrous sheath, including cAMP protein kinase (PKA) subunits and components of the 
Rho signaling pathway [6].  However, there has been no evidence to date supporting a 
direct interaction between glycolytic enzymes and AKAPs found in the fibrous sheath.  
Modification of proteins through the addition of novel amino acid residues, such as the N-
terminal extension of GAPDHS, may help target and bind proteins to the fibrous sheath [37].  
Trypanosome Brucei aldolase A contains a ten residue N-terminal extension that is 
hypothesized to direct localization of this glycolytic enzyme to a structure termed the 
glycosome [70].  A larger form of ALDOA is tightly bound to the mouse fibrous sheath, while 
a smaller form migrating at the expected molecular weight for ALDOA is lost during 
purification [62].  It is possible that spermatogenic-cell specific glycolytic enzymes, including 
ALDOA, are modified through the addition of N-terminal extensions to promote tight binding 
to the fibrous sheath where glycolytic ATP is produced.    
 
Research presented in this dissertation 
The overall goal of this dissertation is to identify and characterize the expression of 
novel spermatogenic-cell specific glycolytic enzymes in order to better understand 
metabolism and the regulation of glycolysis in sperm.  The work presented in chapter two 
details the identification of all aldolase isoforms expressed during mouse spermatogenesis 
using genomic, molecular and proteomic methods.  Three spermatogenic-cell specific 
aldolase transcripts are generated through retrotransposition and alternative splicing of the 
Aldoa gene.  Unique nucleotide sequence in two spermatogenic-cell specific Aldoa 
transcripts encode N-terminal extensions hypothesized to be important for localization of 
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ALDOA to the fibrous sheath, the site of glycolytic ATP production.  Chapter three details 
the kinetic properties of aldolase in mouse sperm and the quaternary structure of sperm-
specific aldolase proteins expressed in E. coli.   Preliminary three-dimensional modeling 
draws attention to unique structural differences in the outer face and near the substrate 
binding pocket of the isoforms, suggesting unique binding and catalytic properties.  Results 
from the aldolase study supported the use of a similar genomic approach to identify all 
retroposed sequences matching glycolytic enzymes in the mouse and human genomes.  
Chapter four summarizes the genomic analysis of the glycolytic pathway, including 
characterization of gene structures in order to identify sequences with novel features, and 
detailed expression analysis of candidate retrogenes in mouse and human testes.  These 
studies provide evidence for the frequent retrotransposition of orthologous genes encoding 
glycolytic enzymes in the mouse and human genome.  Identification of all glycolytic 
enzymes expressed during spermatogenesis is important for understanding sperm 
metabolism, developing new contraceptive strategies, and discovering mutations in 
glycolytic enzymes that impair sperm motility and male fertility.    
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Figure 1.1 
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Figure 1.1.  Mammalian sperm structure and compartmentalization of metabolic 
pathways.  Sperm possess unique cellular structures, including a head and tail, or 
flagellum.  The nucleus and acrosome are localized in the head.  The tail is divided into 
three sections:  the middle piece, the principal piece and the end piece.  Metabolism is 
compartmentalized in the sperm tail.  Mitochondria are compacted in the middle piece, and 
here oxidative phosphorylation occurs.  The principal piece is defined by a highly insoluble 
cytoskeletal structure, the fibrous sheath.  Glycolytic enzymes are localized to the principal 
piece.  (Adapted from [71]).    
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Figure 1.2 
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Figure 1.2.  The glycolytic pathway is modified in mature sperm.  Glucose is 
metabolized by ten sequential enzymatic reactions to yield 2 ATP and pyruvate, which can 
then enter the citric acid cycle.  Enzymes shown in red are encoded by genes that are 
expressed only during spermatogenesis.   
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Figure 1.3 
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Figure 1.3.  Fructose metabolism occurs through an aldolase-dependent pathway.  
Fructose is metabolized by fructokinase to produce fructose-1-phosphate, the substrate for 
fructose-1-phosphate aldolase.  The final product, glyceraldehyde-3-phosphate, enters the 
glycolytic pathway and is metabolized by GAPDH.  TPI is triose phosphate isomerase and 
DHAP is dihydroxyacetone phosphate.   
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CHAPTER 2 
THREE MALE GERMLINE-SPECIFIC ALDOLASE A ISOZYMES ARE GENERATED BY 
ALTERNATIVE SPLICING AND RETROTRANSPOSITION 
 
Abstract 
Enzymes in the glycolytic pathway of mammalian sperm are modified extensively 
and are localized in the flagellum, where several are tightly bound to the fibrous sheath.  
This study provides the first evidence for three novel aldolase isozymes in mouse sperm, 
two encoded by Aldoart1 and Aldoart2 retrogenes on different chromosomes and another by 
Aldoa_v2, a splice variant of Aldoa.  Phylogenetic analyses and comparative genomics 
indicate that the retrogenes and splice variant have remained functional and have been 
under positive selection for millions of years.  Their expression is restricted to the male 
germline and is tightly regulated at both transcriptional and translational levels.  All three 
isozymes are present only in spermatids and sperm and have distinctive features that may 
be important for localization in the flagellum and/or altered metabolic regulation.  Both 
ALDOART1 and ALDOA_V2 have unusual N-terminal extensions not found in other 
aldolases.  The N-terminal extension of ALDOA_V2 is highly conserved in mammals, 
suggesting a conserved function in sperm.  We hypothesize that the N-terminal extensions 
are responsible for localizing components of the glycolytic pathway to the fibrous sheath and 
that this localization is required to provide sufficient ATP along the length of the flagellum to 
support sperm motility.    
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Introduction  
Mammalian spermatogenesis includes three phases:  a mitotic proliferation period 
that expands the number of spermatogonia, a prolonged meiotic prophase allowing 
spermatocytes to undergo recombination followed by two meiotic divisions, and a post-
meiotic period where haploid spermatids differentiate into highly polarized sperm that are 
specialized to achieve fertilization.  The program of gene expression that directs this 
developmental process has several distinct features and produces a large number of 
transcripts that are restricted to spermatogenic cells [1-3].  Microarray analyses estimate 
that at least 4% of the mouse genome produces male germ cell-specific transcripts, 
predominantly during the meiotic and post-meiotic phases of spermatogenesis [4-6].  
Essential processes that occur during these two phases include the generation and 
subsequent packaging of the haploid genome within an extremely condensed nucleus, 
formation of specialized sperm structures such as the acrosome and flagellum, organization of  
surface domains essential for fertilization, and the development of complex signaling and 
metabolic cascades that regulate sperm function and gamete interaction.   Multiple 
mechanisms contribute to this extensive diversification of gene function including gene 
duplication, retrotransposition and alternative splicing.  Many conserved pathways, as well as 
germ cell-specific structures and processes, have unique variants with restricted expression 
during spermatogenesis. 
Glycolysis is an important conserved pathway that has been modified substantially 
during mammalian spermatogenesis.  This central metabolic pathway is composed of ten 
enzymes that convert glucose to pyruvate, with a net production of 2 ATPs per glucose 
molecule.  Pyruvate can be further metabolized in the mitochondria via the Krebs cycle and 
oxidative phosphorylation, or alternatively converted to lactate by lactate dehydrogenase 
(LDH).  Eight glycolytic enzymes and LDH have multiple isoforms with distinct patterns of 
expression in different tissues [7].  At least three of these gene families include members with 
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restricted expression in germ cells.  Two germ cell-specific isozymes with distinct enzymatic 
properties, glyceraldehyde 3-phosphate dehydrogenase-S (GAPDHS) and lactate 
dehydrogenase C (LDHC), are encoded by intron-containing genes that arose by gene 
duplication.  In the mouse Gapdhs is expressed only in spermatids [8, 9], while Ldhc is 
expressed in spermatogenic cells and oocytes [10-12].  Phosphoglycerate kinase-2 (Pgk2), 
which encodes another germ cell-specific isozyme, is an intronless gene that evolved by 
retrotransposition (i.e., a retrogene) from the Pgk1 gene [13, 14].  Although Pgk2 is 
transcribed in primary spermatocytes, the PGK2 protein is translated only in post-meiotic 
spermatids [15, 16].  
Other glycolytic enzymes, including hexokinase 1 (Mori et al., 1993, 1998), 
phosphoglucose isomerase [17], phosphofructokinase 1 [18], aldolase [19] and enolase [20, 
21], have unique structural or functional properties in spermatogenic cells and sperm.  The 
molecular basis for these distinctive properties has not been determined in most cases.  
One exception is HK1-S, the hexokinase 1 isozyme that is derived from alternative splicing 
and lacks the porin-binding domain responsible for binding to mitochondria [22, 23].    
Energy production in sperm is compartmentalized in distinct regions of the flagellum, 
with mitochondria and oxidative phosphorylation restricted to the middle piece and glycolysis 
localized in the longest segment known as the principal piece [24].  Although there are 
differences between species, mammalian sperm typically exhibit a high rate of glycolysis that is 
correlated with motility [25, 26].  Multiple studies indicate that glycolysis provides a significant 
proportion of ATP in both mouse and human sperm [27-29].  Gene targeting studies provide 
compelling evidence that glycolysis in spermatozoa [30] rather than mitochondrial ATP 
production [31] is essential for maintaining sperm motility and male fertility in the mouse.  
Distinctive features of sperm glycolytic enzymes may be important for localization in the 
principal piece and/or altered regulation of this key metabolic pathway.  
Several sperm glycolytic enzymes are difficult to solubilize because they are tightly 
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bound to the fibrous sheath, a cytoskeletal structure that defines the limits of the principal 
piece in the sperm flagellum.  We found that GAPDHS, aldolase A (ALDOA), lactate 
dehydrogenase A (LDHA), and pyruvate kinase remain attached to the fibrous sheath 
throughout a rigorous isolation procedure [8, 32].  GAPDHS is larger than other GAPDH 
family members and contains a novel proline-rich extension at the N-terminus [9, 33] that 
may mediate binding to the fibrous sheath.  Our proteomic and immunoblot analyses 
identified two ALDOA bands in mouse sperm, with the larger 50,000 molecular weight band 
always present in isolated fibrous sheaths [32].  ALDOA, along with several other glycolytic 
enzymes, was also identified in fibrous sheaths isolated from human sperm [34].  Consistent 
with this localization, an earlier study found that 90% of aldolase activity in bovine sperm 
could not be solubilized with detergents [19].  That study also determined that sperm and 
muscle aldolases had distinct kinetic properties.   
The fructose-1,6-bisphosphate aldolase gene family in vertebrates contains three 
well-characterized members:  Aldoa, which is ubiquitously expressed with particularly high 
levels in muscle, aldolase B (Aldob) which is expressed at high levels in liver and kidney, 
and aldolase C (Aldoc) which is predominantly expressed in the nervous system [35-37].  All 
three of these isozymes have molecular weights of ~39,000, significantly smaller than the 
isoform detected in fibrous sheath.  To determine the identity and origin of this larger 
ALDOA isoform, we used genomic, molecular and proteomic methods to examine all the 
aldolase variants expressed during mouse spermatogenesis and present in mature sperm.  
Our analyses identified three spermatogenic cell-specific aldolase isoforms in mouse, two 
encoded by retrogenes and a third resulting from alternative splicing of the Aldoa gene.   
 
Materials and methods 
Genomic analyses to identify Aldoa-related sequences  
Ensembl Mouse BlastView (http://www.ensembl.org/Mus_musculus/blastview) was 
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used to search the mouse genome (NCBI database, mouse build 34) for sequences highly 
related to the mRNA sequence of mouse Aldoa (accession number NM_007438).  
Chromosomal regions containing significant matches were aligned to the mRNA sequence 
of Aldoa using ClustalW (http://www.ebi.ac.uk/clustalw/).  All chromosome numbers included 
refer to Assembly: NCBIm36, December 2005; Genebuild: Ensembl, April 2006; Database 
version: 42.36c.  For each sequence, we identified all insertions and deletions resulting in a 
shift in open reading frame (ORF) and internal stop codons.  We assume that sequences 
containing such insertions/deletions or stop codons are pseudogenes that do not encode 
functional aldolase enzymes.  Intronless sequences that contain a full-length ORF with 
conserved start and stop codons were classified as putative retrogenes.  These included 
sequences found on chromosome 4 and chromosome 12, now termed Aldoart1 and 
Aldoart2.  The Mouse Genome Informatics database (http://www.informatics.jax.org/) 
currently identifies both of these regions as Aldoa pseudogenes.  Aldoart1 contains an 
extended ORF capable of encoding a protein with an additional 55 amino acids at the N-
terminus.  Further genomic comparisons identified a homologous potential coding sequence 
within the first intron of the Aldoa gene on chromosome 7, indicating the existence of an 
additional Aldoa exon.  Transcripts that include this newly identified exon 2 would result in a 
splice variant (Aldoa_v2) that also encodes a larger protein with a novel N-terminus. 
  
Phylogenetic analyses  
Phylogenetic analyses were performed with two sets of sequences.  The first set 
comprises nucleotide sequences for the ORFs of mouse Aldoa, Aldob, Aldoc, Aldoart1, 
Aldoart2 and their orthologs in rat, human and chimpanzee.  All these sequences were 
obtained from Ensembl.  To identify orthologous sequences of the predicted mouse 
retrogenes, we used the Aldoart1 and Aldoart2 sequence as queries in BLAST searches in 
each of these additional species.  Putative matches were then tested for conservation of 
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synteny with sequences flanking the mouse retrogenes and for presence of a conserved 
ORF.  The second set of sequences includes the 165 nucleotides of mouse Aldoart1 
encoding 55 additional amino acids at the N-terminus, the 162 nucleotides of Aldoa_v2 that 
encode a similar 54 amino acid sequence at the N-terminus, and the homologous 
sequences in rat, human, chimpanzee and macaque identified through BLAST searches in 
the appropriate species.  Each set of sequences were aligned separately using ClustalW.  
All phylogenetic analyses were performed using the PHYLIP phylogeny inference software 
package, version 3.6 (http://evolution.genetics.washington.edu/phylip.html).  For each set of 
sequences, we generated 100 bootstrapped datasets using the Seqboot program.  We then 
determined the phylogeny of the aldolase gene family with a distance matrix method 
(Neighbor) using distances obtained with the Dnadist program, a maximum likelihood 
method without a molecular clock (Dnaml), and a maximum parsimony method (Dnapars).  
The Consense program was used to construct a majority-rule consensus tree.  
 
EST database searches 
Sequences for the full-length Aldoa mRNA, individual exons of this gene including 
the proposed alternative exon 2, Aldoart1 and Aldoart2 were used as queries in BLAST 
searches against the mouse EST database, using the NCBI nucleotide-nucleotide BLAST 
(blastn) software.  The EST database includes libraries from several cell types isolated from 
testis including type A spermatogonia, type B spermatogonia, pachytene spermatocytes, 
round spermatids and Sertoli cells [38].  EST libraries are also available from cell lines 
produced from Leydig cells.  To query specific EST libraries, searches were completed 
using either tissue type or testicular cell type as a limiting field (i.e., muscle, brain, testis or 
testicle, spermatogonia, spermatocyte and spermatid).  Positive hits from libraries derived 
from pooled tissues were excluded.  ESTs with very high levels of identity for substantial 
contiguous sequences (>98% identity for >100 bp) were scored as positive.  Positive ESTs 
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were then blasted against the mouse genomic database using Ensembl Mouse BlastView, 
and the best genomic sequence match (with at least 98% identity) was used to identify the 
gene from which the EST was transcribed.  
 
Tissue and cell isolations 
Outbred CD-1 mice and Sprague-Dawley rats were obtained from Charles River 
(Raleigh, NC) and inbred strains (C57BL/6J and A/J) were obtained from the Jackson 
Laboratory (Bar Harbor, ME).  All procedures involving animals were approved by the 
University of North Carolina at Chapel Hill Animal Care and Use Committee and conducted 
in accordance with the Guide for the Care and Use of Laboratory Animals (Institute for 
Laboratory Animal Research, National Academy of Sciences).  Testes and other tissues 
were processed immediately or quick-frozen in liquid nitrogen and stored at -70oC.  Mixed 
germ cells were isolated by sequential enzymatic dissociation of testes from 8-day-old, 17-
day-old, or adult mice  [39].  Spermatogonia (92% purity, including type A through type B 
spermatogonia) were isolated from mixed germ cells from 8-day-old mice by differential 
plating [40].  Sertoli cells were isolated from 17-day-old mice as described previously [41].  
Pachytene spermatocytes, round spermatids, and condensing spermatids were purified from 
adult mixed germ cell suspensions by unit gravity sedimentation [39].  Both pachytene 
spermatocytes and round spermatids (steps 1-8) had purities >90%.  Condensing 
spermatids contained 30-40% nucleated cells (steps 9-16 spermatids) and cytoplasts 
derived primarily from these same cells.   
Mouse and rat sperm were collected from the cauda epididymis following a 15 min 
incubation of clipped tissue at 37ºC in phosphate buffer saline with protease inhibitors (PBS 
+ PI) containing 140 mM NaCl, 10 mM phosphate buffer (pH 7.4) and Complete protease 
inhibitor cocktail (Roche Diagnostics, Mannheim, Germany).  Cryopreserved human sperm 
samples from healthy donors were provided by the Andrology Laboratory, Department of 
  27
Obstetrics and Gynecology, University of North Carolina School of Medicine.  These 
samples were washed twice with PBS to remove seminal plasma. 
 
RT-PCR to detect transcription of Aldoa-related genes 
Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA) from tissues or cells 
pooled from at least three mice, including brain, heart, ovary, kidney, spleen, liver, juvenile 
(8 - 34 days of age) and adult testis, and purified testicular cells.  Genomic DNA 
contamination was removed from RNA preparations using the Qiagen RNeasy Midi Kit 
(Qiagen Incorporation, Valencia, CA).  RNA was quantified using the NanoDrop 
spectrophotometer (NanoDrop Technologies, Wilmington, DE).  Equal loading and quality 
was confirmed using the RNA 6000 Nano Assay (Agilent Technologies, Waldbronn, 
Germany). 
Reverse transcription followed by gene-specific polymerase chain reaction (cMaster 
RTplusPCR System, Eppendorf, Hamburg, Germany) was used to amplify transcripts from 
total RNA samples.  Primers were designed to amplify and incorporate α-[32P]-dCTP into the 
same size product (530 base pairs) from Aldoa (including both the ubiquitously expressed 
Aldoa_v1 transcript and the predicted Aldoa_v2 transcript), Aldoart1 and Aldoart2.  The 
forward primer sequence was 5’AGAAGGCAGATGTGGACGTCC3’ and the reverse primer 
sequence was 5’GGCACTGTGCGACGAAGTGCTGTGAC3’.  Both primers are 100% 
identical to matching sequences in Aldoa, Aldoa_v2, Aldoart1, and Aldoart2.  Filled triangles 
in Fig. 2.2.1 denote the location of these primers in each gene.  Following PCR amplification 
with both primer sets, the products were digested with the HaeIII restriction enzyme (New 
England BioLabs, Ipswich, MA).  Unique HaeIII restriction sites in each amplified product 
produced fragments with distinct sizes that were resolved by electrophoresis on 5% 
acrylamide gels at 95 watts for 2 h.  Appropriate controls (a cDNA clone for Aldoa, and BAC 
clones for Aldoart1 [RP24-191C1] (Invitrogen, Carlsbad, CA) and Aldoart2 [RP23-63H11]) 
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were used as template in parallel PCR reactions to confirm the expected digestion pattern.  
Gels were exposed to Super RX x-ray film (Fujifilm, Tokyo, Japan) using intensifying 
screens to detect incorporation of α-[32P]-dCTP into amplified products. 
For semi-quantitative analysis of RT-PCR products, we first determined the linear 
phase for PCR amplification by varying the amount of input RNA and the number of 
amplification cycles.  Once conditions for the linear phase of amplification were established, 
RT-PCR was repeated as described above with RNAs (75 ng/reaction) from isolated 
testicular cells (pachytene spermatocytes, round spermatids, condensing spermatids and 
Sertoli cells) using triplicate reactions from two preparations of each cell type.  For each 
reaction, incorporation of α-[32P]-dCTP into HaeIII-digested products was measured by 
densitometry using the Fluor-S MultiImager (Bio-Rad, Hercules, CA).  Corrections were 
made for varying amounts of α-[32P]-dCTP incorporated into each gene product due to 
nucleotide differences and for HaeIII-digested PCR fragments that were outside the 
resolution range of our gels.   
A second set of primers (open triangles in Fig. 2.2.1) was used to amplify and 
incorporate α-[32P]-dCTP into products from the N-terminal regions of Aldoa and Aldoart1.  
The forward primer sequence for this reaction was 5’CCGCGTTCGCTCCTTAGT3’ and the 
reverse primer sequence was 5’ATCTGCAGCCAGGATGCCC3’.  Both primers are 100% 
identical to the matching sequences in the  Aldoa_v1 and Aldoa_v2 transcripts, and will 
amplify different-sized RT-PCR products from each transcript.  However, the forward primer 
contained one mismatched residue when amplifying Aldoart1 (5’ 
CCG/ACGTTCGCTCCTTAGT3’).  Products from Aldoa_v2 and Aldoart1 can be 
distinguished following HaeIII-digestion, since only the Aldoa_v2 product is cleaved by this 
enzyme. [32P]-labeled RT-PCR products were resolved on 5% polyacrylamide gels and 
detected by exposure to film using intensifying screens.   
Reverse transcription of RNA from CD1 testis using an oligo d(T) primer generated a 
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testis cDNA sample used for full length subcloning of Aldoa, Aldoa_v2, Aldoart1, and 
Aldoart2.  All four aldolase A genes were PCR amplified by gene-specific primer sets.  The 
following primer pairs were using for PCR amplification of each Aldoa-related transcript:  
Aldoa (forward primer:  5’ACGAGGTTCTGGTGACCCTA3’, reverse primer:  
5’GTGATGGGAAAGAGCCTGAA3’), Aldoa_v2 (forward primer:  
5’GAATTCATGGCAACGCACAG3’, reverse primer:  5’CTCGAGTTCAATAGCAAGTGG3’), 
Aldoart1 (forward primer:  5’CGGAATTCATGGCAACGCACAGGCA3’, reverse primer:  
5’AGCGTCGACACATGAGGGCA3’), and Aldoart2 (forward primer:  
5’GAATTCATGTCTTACCCCTACC3’, reverse primer:  5’CTCGAGACCTCTGCTCAGTA3’).  
Amplified products were subcloned into the pCR®4-TOPO® vector using the TOPO TA 
Cloning® Kit for Sequencing (Invitrogen, Carlsbad, CA).  Positive clones were confirmed by 
EcoRI restriction digest and were directly sequenced using M13 forward and reverse 
primers by the UNC-CH Genome Analysis Facility.  All three newly identified mouse 
aldolase A genes were deposited into GenBank using the following accession numbers:  
Aldoa_v2 (EF662059), Aldoart1 (EF662061), and Aldoart2 (EF662062). 
 
Immunoblotting of ALDOA-related proteins 
Proteins were extracted from tissues or isolated cells by homogenization in lysis 
buffer (2% SDS, 100 mM DTT, 125 mM Tris pH 6.8, 18% glycerol).  The lysates were 
centrifuged at 16,000 x g for 10 min at 4ºC.  The protein concentration in the supernatants 
was determined using the micro BCA assay according to the manufacturer’s instructions 
(Pierce Biotechnology, Rockford, IL).  Samples with equal protein amounts were separated 
by SDS polyacrylamide gel electrophoresis (SDS-PAGE) on 10% polyacrylamide gels and 
electrophoretically transferred to Immobilon-P PVDF (polyvinylidene fluoride) membranes 
(Millipore Corp, Bedford, MA).  Protein transfer and equal loading were confirmed by 
staining the membranes with 0.1% Coomassie blue R250 in 45% methanol, 10% acetic 
  30
acid.  Membranes were destained, rinsed with TBS-T (140 mM NaCl, 3 mM KCl, 0.05% 
Tween-20, 25 mM Tris-HCl, pH 7.4) and incubated in blocking buffer (5% nonfat dry milk in 
TBS-T) overnight at 4ºC.  Membranes were then incubated for 1 h at room temperature with 
a polyclonal antibody raised against purified rabbit skeletal muscle aldolase (Polysciences, 
Warrington, PA) diluted 1:2000 in blocking buffer.  After three 15-min washes with TBS-T, 
the membranes were incubated for 20 min at room temperature with secondary antibody 
(affinity-purified horseradish peroxidase-conjugated rabbit anti-goat IgG, KPL, Gaithersburg, 
MD) diluted 1:10,000 in blocking buffer.  TBS-T washes were repeated and immunoreactive 
proteins were detected by enhanced chemiluminescence using the SuperSignal West Pico 
substrate (Pierce Biotechnology, Rockford, IL) and HyBlot CL autoradiography film (Denville 
Scientific, Metuchen, NJ). 
 
Proteomic analysis of mouse sperm proteins 
Mouse sperm were sonicated to separate sperm heads and tails, and were further 
fractionated to obtain purified fibrous sheath preparations as described previously [32].  
Briefly, fragmented sperm tails were pelleted at 32,500 x g after removing the sperm heads 
by low-speed centrifugation. Soluble sperm proteins released by sonication were 
precipitated with 10% trichloroacetic acid.  Fibrous sheaths were isolated from the tail pellets 
by sequential incubations in Triton X-100 extraction buffer (1% Triton X-100, 2 mM 
dithiothreitol [DTT], 1 mM EDTA, 1 mM EGTA, 2 mM PMSF, 50 mM Tris-HCl, pH 9.0 and 
PI), potassium thiocyanate extraction buffer (0.6 M potassium thiocyanate, 2 mM DTT, 50 
mM Tris-HCl, pH 8.0), and urea extraction buffer  (6 M urea, 20 mM DTT, 50 mM Tris-HCl, 
pH 8.0).  The final urea-insoluble pellet contained purified fibrous sheaths.    
Proteins from the soluble, sperm tail and fibrous sheath fractions were resuspended 
in 2X SDS sample buffer (4% SDS, 18% glycerol, 125 mM Tris-HCl, pH 6.8) containing 50 
mM TCEP reducing agent (Tris(2-carboxyethyl)phosphine, Pierce Biotechnology, Rockford, 
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Il), heated at 95ºC for 10 min, and separated by SDS-PAGE using pre-cast 10% Tris-HCl 
Ready Gels (Bio-Rad, Hercules, CA).  The BenchmarkTM Protein ladder (Invitrogen, 
Carlsbad, CA) was also resolved on these gels to determine approximate molecular weights 
of unknown proteins.  SDS gels were fixed for 1 h at room temperature with gentle agitation 
in 45% methanol, 10% acetic acid in deionized water.  Fixed gels were stained with SYPRO 
Ruby (Molecular Probes, Eugene, OR) overnight at room temperature with gentle agitation, 
followed by two 30-min washes in 10% methanol, 7% acetic acid in deionized water.  Gels 
were stored in SYPRO Ruby stain until processed.  
Gel bands corresponding to aldolase proteins identified by immunoblotting were cut 
from gels and processed using an in-gel digestion protocol as described previously [42].  
Peptides from the digested proteins were resuspended in 5% acetonitrile/95% water/0.1% 
trifluoroacetic acid (Buffer A) to facilitate liquid chromatography.  Following digestion, the 
samples were subjected to MALDI-MS (Matrix-Assisted Laser Desorption Ionization-Mass 
Spectrometry) and MS/MS analysis using the Applied Biosystems 4700 Proteomics 
Analyzer (Applied Biosystems Incorporated, Foster City, CA).  The spectra were then 
searched against the NCBI and MSDB databases using the MASCOT search engine.  After 
protein identification, samples were analyzed by liquid chromatography (LC)-MALDI-MS.  
Briefly, peptides in the sample (5 µL) was separated on a reverse-phase C18 nano-HPLC 
column (Dionex Corp., Sunnyvale, CA) using an Agilent 1100 Capillary HPLC system 
(Agilent Technologies Inc. Santa Clara, CA) with a post-pump split to deliver 250 nL/min 
through a manual injection valve.  The column was coupled to a Probot Microfraction 
Collector (Dionex Corp., Sunnyvale, CA).  A gradient from 5-65% Buffer B (95% 
acetonitrile/0.09% TFA) was run and the column eluate was spotted along with an 
equivalent volume of 60% acetonitrile supplied by the sheath flow from the Probot syringe 
pump.  After drying, the fractions were overlaid with a saturated solution of α-cyano-4-
hydroxycinamic acid in 50% acetonitrile/20 mM ammonium citrate.  Spectra were collected 
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and examined for the presence of aldolase isoform-specific peptide masses.  Peptides 
within 100 ppm of predicted masses were subjected to MS/MS to confirm their identity.   
 
Results 
Genomic analyses predict two Aldoa-related retrogenes and a novel Aldoa splice variant 
Ensembl BLAST searches with the coding sequence of the Aldoa gene on 
chromosome 7 detected related sequences on ten additional mouse chromosomes 
(Supplemental Table 2.1).  These sequences lack introns and are consistent with a previous 
report of several Aldoa pseudogenes in mouse derived from multiple retrotransposition 
events [43].  In contrast, we did not detect retroposed sequences related to Aldob or Aldoc 
in comparable BLAST searches.  Two of the Aldoa-related sequences have conserved full-
length ORFs (including start and stop codons), suggesting that they may be functional 
retrogenes.  These predicted retrogenes are located on chromosome 4 (Aldoart1; 
chromosome 4, minus strand, 72,337,671-72,339,071, Ensembl gene ID:  
ENSMUSG00000059343) and chromosome 12 (Aldoart2; chromosome 12, plus strand, 
56,483,303-56,484-873, Ensembl gene ID:  ENSMUSG00000063129).  The start and end 
positions of the retrogenes were determined based on sequence alignments to Aldoa, 
combined with the identification of ESTs spanning both the 5’-UTR and 3’-UTR of each gene 
(see below).   
Aldoart2 encodes a protein of the same size as ALDOA (Fig. 2.1, white boxes 
corresponding to homologous coding exons of Aldoa).  The 5’- and 3’-UTRs of Aldoart2 
contain regions with homology to the 5’- and 3’-UTRs of Aldoa (boxes with diagonal lines), 
along with unique sequences (boxes with horizontal lines) that are proximal and distal to the 
Aldoa-homologous regions.  Aldoart1 is predicted to encode a larger protein because it 
contains sequence (black box, chromosome 4, minus strand, 72,338,786-72,338,943) that 
extends the ORF by 165 nucleotides at the N-terminus.  
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a 55-amino acid N-terminal extension that shows no homology with any of the previously 
described aldolase isoforms.   The remaining Aldoart1 coding sequence (white boxes), 5’-
UTR and initial segment of the 3’-UTR (boxes with diagonal lines) are homologous to Aldoa.  
Only the terminal portion of the Aldoart1 3’-UTR has unique sequence that is not 
homologous to Aldoa or Aldoart2.   
The Aldoart1 sequence that encodes the novel N-terminal extension is 90% identical 
to a region within the first intron of Aldoa, providing evidence that Aldoa contains a 
previously unidentified exon.  As shown at the top of Figure 2.1, alternative splicing of Aldoa 
can generate both the ubiquitously transcribed mRNA with eight coding exons (Aldoa_v1) 
and a longer transcript (Aldoa_v2) from nine exons, including the newly identified exon 2 
(154 nucleotides, chromosome 7, minus strand, 126,590,193-126,590,347).  The first 21 
nucleotides of exon 3 are part of the 5’UTR in Aldoa_v1, but are part of the coding sequence 
in Aldoa_v2.  The ORF of Aldoa_v2 contains an additional 162 nucleotides encoding a 54-
amino acid N-terminal extension.  There is an in-frame stop codon immediately upstream of 
the predicted start codon in both Aldoa_v2 and Aldoart1.   
 
Aldoart1 and Aldoart2 are derived from Aldoa and arose in the rodent lineage 
Phylogenetic analyses of coding sequences conclusively demonstrate that Aldoart1 
and Aldoart2 belong to the Aldoa subfamily (Fig. 2.2).  Both Aldoart1 and Aldoart2 arose by 
retrotransposition in the rodent lineage after the primate-rodent split.  All phylogenetic 
methods robustly predict that Aldoart2 arose prior to the divergence of rat and mouse.  This 
prediction was confirmed by the identification of the orthologous sequence for Aldoart2 on 
rat chromosome 6 (plus strand, position 75,812,016 – 75,813,706).  The rat Aldoart2 has a 
conserved ORF with 94% identity to mouse Aldoart2 (not shown), supporting the hypothesis 
that it is a functional retrogene in both species.  It is uncertain whether Aldoart1 arose before 
or after the rat-mouse split.  Although phylogenetic analyses support a retrotransposition 
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event just before the divergence of these two lineages, we were unable to find evidence for 
a homologous sequence anywhere in the rat genome, including the region of conserved 
synteny (90.5 Mb on rat chromosome 5).  We conclude that the ORF and critical amino 
acids of both retrogenes have been conserved for a minimum of 15 million years in the 
mouse lineage for Aldoart1 and for a much longer period in both the mouse and rat lineages 
in the case of Aldoart2.  However, the retrogenes have evolved with higher substitution rates 
than other aldolase genes in rat and mouse, as indicated by the relative length of the 
retrogene branches in the phylogenetic tree (Fig. 2.2). 
 
Aldoa_v2 is conserved in multiple mammalian species 
 We also performed phylogenetic analyses with the nucleotide sequences encoding 
the novel N-terminal extensions of Aldoa_v2 from mouse (Fig. 2.3A, black segments of exon 
2 and 3) and four other mammalian species, and mouse Aldoart1.  The tree (Fig. 2.3B) 
replicates the known divergence order of these species and supports the sequence of 
events depicted in Figure 2.  The most remarkable feature of this tree is the striking 
difference in substitution rate in Aldoart1 compared to Aldoa_v2.  When amino acid 
sequences are compared (Fig. 2.3C), the N-terminal extensions of ALDOART1 and mouse 
ALDOA_V2 have 12 amino acid differences (78% identity).  The retention of an ORF with 
numerous substitutions confirms that the evolution of Aldoart1 is not simply the result of 
purifying selection, but most likely involves positive selection for novel functions.  
 
The ALDOA-related isozymes have distinct amino acid sequences 
Excluding the N-terminal extensions, the predicted amino acid sequences of 
ALDOART1 and ALDOART2 are 95.3% and 95.1% identical to ALDOA, respectively, while 
these isoforms are 92.3% identical to each other (Fig. 2.4).  Active site residues [44] are 
conserved among all aldolase isoforms (Fig. 2.4, boxed residues).  Both ALDOART1 and 
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ALDOART2 contain unique amino acids that are not found in any other ALDO-related 
proteins (indicated by white letters on a black background).  When the predicted amino acid 
sequences of mouse and rat Aldoart2 are aligned, eight of the unique amino acids are 
conserved, including Y3, D130, G133, Q140, K156, S246, P266, and E348.  ALDOART1 
and ALDOART2 also contain residues that are identical to ALDOB and/or ALDOC (residues 
highlighted in grey).  In ALDOART1 there are three adjacent amino acids (MGN, amino 
acids 95-97) between the first two active site residues that are identical to the homologous 
sequence in ALDOB (amino acids 39-41), but are different from the homologous IAK 
sequence in ALDOA.  This region contains two amino acids (I39 in ALDOA and G40 in 
ALDOB, arrows in Fig. 2.4) that have been identified as isozyme-specific residues based on 
sequence conservation [45].   ALDOART1 also contains F112 in its sequence (arrow), which 
aligns with another ALDOB-specific residue (F58 in ALDOB).   
 
ESTs support the restricted expression of Aldoa-related retrogenes  
We searched mouse EST databases in our initial assessment of whether the 
predicted Aldoa-related retrogenes and splice variant are transcribed (Table 2.1).  As 
expected, in silico analyses detected abundant transcripts for Aldoa in muscle, Aldob in 
liver, and Aldoc in brain.  Transcripts for Aldoa, but not Aldob or Aldoc, were detected in 
testis.  Multiple Aldoart1 and Aldoart2 ESTs were identified, mainly in testis libraries.  Only 1 
of 10 Aldoart1 ESTs was detected in a library of unknown origin and 3 of 33 Aldoart2 ESTs 
were detected in a spleen library.  However, this spleen library also contains a similar 
number of ESTs from Prm1, a male germ cell-specific transcript (accession numbers 
AA290514, AI509226, and AI661727).  ESTs specific for the alternatively spliced exon 2 of 
Aldoa_v2 were found in libraries from testis, retina, a mammary tumor cell line (RCB0527) 
and other carcinomas.  Each EST was blasted against the mouse genome to confirm the 
gene from which it was transcribed (>98% identity for >100 bp).  EST analyses indicate that 
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the Aldoart2 ortholog in rat is also expressed in the testis.   
EST libraries are available for germ cells isolated at distinct stages of 
spermatogenesis and for testicular somatic cells, including Sertoli cells from the 
seminiferous epithelium and cell lines derived from the interstitial Leydig cells that are 
responsible for testosterone production.  Aldoa transcripts were detected in Leydig and 
Sertoli cells and at earlier stages of spermatogenesis, including type B spermatogonia and 
pachytene spermatocytes (Table 2.1).  Aldoart1 and Aldoart2 transcripts were detected only 
in round spermatids, which undergo haploid differentiation following meiosis.  Frequency 
analysis supports the abundant expression of Aldoart1 and Aldoart2 in round spermatids 
(Table 2.2) compared to other testicular cell types (Table 2.2) and other tissues (Table 2.3).  
These EST analyses provide support for the expression of Aldoa-related retrogenes and the 
Aldoa_v2 splice variant, with restricted expression of the retrogenes primarily during the 
later stages of spermatogenesis.   
ESTs preferentially span the 3’ and 5’ ends of transcripts.  The 3’ ends of the 
Aldoart1 and Aldoart2 transcripts and the 5’ end of Aldoart2 were determined directly from 
the alignment of multiple ESTs to the corresponding genomic sequences.  Since the 5’-
UTRs of Aldoart1 and Aldoa are homologous, we predict that Aldoart1 has a transcription 
start site that is comparable to Aldoa, although available 5’-derived ESTs do not contain the 
first 88 bp of the predicted 5’-UTR sequence.   
 
RT-PCR confirms restricted transcription of Aldoa_v1, Aldoa_v2, Aldoart1 and Aldoart2 in 
the testis 
Although there is high sequence similarity between Aldoa, Aldoart1 and Aldoart2, we 
developed an RT-PCR strategy using a single primer pair followed by HaeIII digestion to 
distinguish among transcripts from these genes (Fig. 2.5A, also see Materials and Methods).  
Following RT-PCR and HaeIII digestion, we observed restriction fragments characteristic of 
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Aldoa transcripts (Aldoa_v1or Aldoa_v2) in all tissues examined (Fig. 2.5B).  Two distinct 
cleavage products each from Aldoart1 and Aldoart2 mRNAs were seen only in testis.  
Products were not amplified when the RT enzyme was omitted, confirming that the observed 
products were not derived from contaminating genomic DNA (data not shown).  Analysis of 
RNAs isolated from the testes of juvenile mice (middle panel, Fig. 2.5B) indicated that 
Aldoart1 and Aldoart2 transcripts are both expressed beginning at 20 days of age, 
coincident with the appearance of round spermatids in the developing testis.  PCR products 
specific for each of these retrogenes were present in testis RNAs isolated throughout 
subsequent pubertal development between 22 and 34 days of age (not shown).  The 
appearance of Aldoart1 and Aldoart2 transcripts at day 20 was confirmed by three 
independent PCR replicates.  
Semi-quantitative RT-PCR using the same primer set (right panel, Fig. 2.5B) 
followed by densitometry of the resulting products (Fig. 2.5C) showed that Aldoart2 mRNA 
levels were elevated compared to other Aldoa-related transcripts, both in testis and in 
isolated round spermatids (R) and condensing spermatids (C).  Aldoart1 mRNA was 
detected in both round and condensing spermatids, at levels comparable to the expression 
of Aldoa and/or Aldoa_v2 transcripts (Fig. 2.5B, C).  When analyzed in the same linear 
range of PCR amplification, the levels of all Aldoa-related transcripts were reduced or 
absent in pachytene spermatocytes (P) and Sertoli cells.  Minor contamination of isolated 
pachytene spermatocytes with round spermatids may account for the Aldoart2 signal 
detected in this cell population.   
Expression of the novel N-terminal coding sequences in Aldoa_v2 and Aldoart1 was 
confirmed using a similar RT-PCR strategy to amplify regions near the 5’ end of the Aldoa 
and Aldoart1 transcripts (Fig. 2.6A).  Primers used in these assays do not amplify a product 
from the Aldoart2 transcript.  HaeIII restriction digestion cleaves only the Aldoa_v2 RT-PCR 
product, generating distinct bands from Aldoa_v1, Aldoa_v2 and Aldoart1 transcripts that 
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are resolved by gel electrophoresis.  This assay detected expression of both Aldoa_v2 and 
Aldoart1 transcripts only in testis (Fig. 2.6B).  Aldoart1 transcripts first appeared at 20 days 
of age (Fig. 2.6C), confirming our previous analyses (Fig. 2.5B).  In contrast, Aldoa_v2 
transcripts were detected throughout postnatal development of the testis between 8 and 34 
days of age (Fig. 2.6C), indicating that this splice variant is expressed during earlier stages 
of spermatogenesis.   
 
Proteins encoded by Aldoa_v1, Aldoart1 and Aldoart2 are present in mouse sperm  
Our initial proteomic and Western analyses identified two ALDOA bands, with 
apparent molecular weights of ~39,000 and 50,000, in fibrous sheaths isolated from mouse 
sperm [32].  Western blotting detected a ~39,000 molecular weight aldolase isoform in the 
soluble fraction following sonication of sperm (soluble, Fig. 2.7B) and in isolated sperm tails 
(tail P, Fig. 2.7B).  Small amounts of this protein were sometimes detected in the fibrous 
sheath fraction [32].   In contrast, the 50,000 molecular weight aldolase band was 
consistently enriched in isolated fibrous sheaths (FS, Fig. 2.7A and B).   Detailed proteomic 
analyses of these bands identified unique peptide sequences that match the three ALDOA-
related isoforms expressed during spermatogenesis (Fig. 2.7A, Supplemental Figs. 2.1-2.3).  
Peptide sequences identified in the 39,000 molecular weight band from the soluble sperm 
fraction (Fig. 2.7A) matched the predicted amino acid sequence of ALDOART2 
(Supplemental Fig. 2.1).  We did not detect peptides unique to the somatic ALDOA isoform 
in this band, even though in silico tryptic digestion predicts that there are at least six 
peptides with sufficient difference to be assigned only to ALDOA.    
Both Aldoa_v2 and the Aldoart1 retrogene encode larger proteins with 54 and 55 
additional amino acids at the N-terminus, respectively.  Our proteomic analyses identified 
peptide sequences matching each of these novel N-terminal sequences in the 50,000 
molecular weight aldolase band that is enriched in isolated fibrous sheaths (Fig. 2.7A, 
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Supplemental Figs. 2.2B and 2.3B).  Additional peptide sequences corresponding to other 
regions of ALDOA_V2 or ALDOART1 were also identified (Supplemental Figs. 2.2 and 2.3, 
respectively).  
 
The larger ALDOA-related isoforms are synthesized late during spermatogenesis  
Western analysis with a polyclonal antibody raised against rabbit muscle aldolase 
detected a 50,000 molecular weight band in mouse sperm (Fig. 2.8A) and testis (Fig. 2.8B), 
but not in several other tissues (Fig. 2.8A).  We did not detect this band in mammary gland 
(virgin or lactating) or retina (data not shown), suggesting that Aldoa_v2 transcripts detected 
by EST analysis in these tissues may represent artifacts or may not be translated.  Despite 
the appearance of Aldoart1 transcripts in round spermatids and Aldoa_v2 transcripts during 
earlier stages of spermatogenesis (Figs. 2.5 and 2.6), the larger ALDOA-related protein 
band was first detected late in spermatogenesis in condensing spermatids (C in Fig. 2.8B).   
This protein was not detected in germ cells at earlier stages of spermatogenesis or in Sertoli 
cells.  Therefore, expression of Aldoa_v2 and Aldoart1 during spermatogenesis appears to 
be regulated at both transcriptional and translational levels.    
A ~50,000 molecular weight aldolase is also present in rat and human sperm (Fig. 
2.8C).  Alternatively spliced Aldoa_v2 transcripts are likely to encode this isoform, since we 
did not identify Aldoart1 retrogenes in either of these species.  This result, along with the 
high level of sequence conservation across species (Fig. 2.3C), strongly supports a 
functional role for the extra amino acid residues located at the N-terminus of ALDOA_V2 
and ALDOART1.  
 
Discussion    
This study identifies three new aldolase isozymes in mouse with restricted 
expression during male germ cell development.  All three isozymes first appear late during 
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the haploid phase of spermatogenesis and are retained in mature sperm.  ALDOART1 and 
ALDOART2 are encoded by Aldoa-related retrogenes which arose in the rodent lineage.  
ALDOA_V2 is a splice variant of Aldoa that is conserved in several mammalian species, 
including human.  Both ALDOART1 and ALDOA_V2 have novel N-terminal extensions that 
may be responsible for tight binding to the fibrous sheath.  We hypothesize that these N-
terminal extensions are important for the proper localization of glycolytic ATP production, 
required for sperm motility.  Our data exemplify the diverse mechanisms that generate 
genes with restricted expression patterns and novel functions in the germline, and illustrate 
the role of positive selection in maintaining expression of newly evolved genes with unique 
attributes. 
Retrotransposition is a common feature of mammalian evolution, producing >4,800 
retrotroposed sequences in the mouse genome [46, 47] and ~8,000 in the human genome 
[47-49].  LINE-1 transposable elements facilitate this process, initiating reverse transcription 
of an mRNA and insertion of the resulting intronless sequence into the genome at a new 
location [50].  Only those retrotransposition events that occur in the germline are heritable 
and, therefore, can be exploited by natural selection to generate new gene family members.  
Although most retroposed sequences are pseudogenes incapable of coding functional 
proteins, EST analyses indicate that >1,000 human retroposed sequences may be 
transcribed [51].  Further studies have confirmed that at least 100 of these sequences are 
functional retrogenes, with many exhibiting specific roles during spermatogenesis [48, 51-
53].  We identified 17 retroposed sequences derived from the ancestral Aldoa gene located 
on mouse chromosome 7 (Supplemental Table 2.1), but none from Aldob or Aldoc, 
consistent with the observation that genes with multiple retroposed copies are frequently 
housekeeping genes that are highly expressed in the germline [47, 49].  Only Aldoart1 and 
Aldoart2, which arose from independent retrotransposition events in the rodent lineage, 
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have full-length conserved ORFs.  These retrogenes, like Pgk2 [13, 14], contribute to the 
diversity of the glycolytic pathway in the male germline.     
It has been proposed that expression of retrogenes during spermatogenesis is 
facilitated by a transcriptionally permissive environment [54, 55], particularly during the 
haploid stages when multiple components of the RNA polymerase II transcription machinery 
are substantially upregulated [56, 57].  Both Aldoart1 and Aldoart2 mRNAs appear in the 
testis at 20 days of age and are selectively expressed in spermatids, suggesting that they 
may share common regulatory mechanisms.  Although the promoters of these retrogenes 
have not been defined, comparison of upstream flanking sequences indicates that they are 
not derived from Aldoa, their ubiquitiously expressed progenitor gene.   
Unique constituents with restricted expression in spermatogenic cells have been 
identified in the multi-protein complexes required for transcriptional initiation [1, 3, 58, 59], 
alternative splicing [3, 59, 60], and 3’-processing of mRNAs [60].  Alterations in these 
processes contribute to the complexity of gene expression during spermatogenesis.  
Analysis of human ESTs indicates that the testis, along with brain and liver, have the highest 
frequencies of alternative splicing [61].  In this study, identification of the Aldoart1 retrogene 
led to the discovery of an alternatively spliced exon that encodes an N-terminal extension of 
ALDOA.  The Aldoa_v2 splice variant, which served as the template for the Aldoart1 
retrogene, is expressed predominantly in testis.  The restricted expression of this 
alternatively spliced exon and its conservation across distantly related species provide 
evidence that the encoded N-terminal sequence has an important functional role in male 
germ cells. 
Western analysis demonstrated a delay in translation of the larger aldolases 
encoded by Aldoart1 and the Aldoa_v2 splice variant.  Storage of mRNAs and delayed 
translation are common features of mammalian spermatogenesis, particularly during the 
haploid period of differentiation where extensive morphogenesis continues for a week or 
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longer after transcription ceases [2, 62].  Although Aldoa_v2 is transcribed throughout 
spermatogenesis and Aldoart1 is initially transcribed in round spermatids, the 50,000 
molecular weight aldolase band was first detected in condensing spermatids, which appear 
in the testis during postnatal development approximately one week later than the round 
spermatids.  GAPDHS [8, 63] and PGK2 [64, 65], two additional spermatogenesis-specific 
isoforms in the glycolytic pathway, are also synthesized in condensing spermatids following 
significant periods of  translation repression.  Both global and mRNA-specific mechanisms 
may regulate the translation of Aldoart1 and Aldoa_v2, along with many other mRNAs 
transcribed during meiosis or the initial haploid phase of spermatogenesis [66].   
Novel features of the newly identified ALDOA-related isozymes, including their 
restricted expression and sequence diversity, suggest neofunctionalization and positive 
selection within the Aldo gene family.  ALDOA, ALDOB and ALDOC, the three known 
aldolase isozymes in vertebrates, catalyze the reversible cleavage of fructose-1,6-
bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate [67, 68].  
ALDOA and ALDOC preferentially catalyze the cleavage reaction essential for glycolysis, 
while the catalytic properties of ALDOB favor the reverse reaction required for 
gluconeogenesis [35, 67, 69, 70].  ALDOB also cleaves fructose-1-phosphate, a reaction 
that is essential for fructose metabolism [37, 71].  Amino acid differences in the ALDOA-
related isozymes may contribute to distinctive enzymatic or structural properties, as reported 
for bovine sperm aldolases [19].  Three of the amino acids in Aldoart1 (M95, G96, F112) 
that match ALDOB rather than ALDOA have been identified as isozyme-specific residues 
[45].  The Aldoart1 MGN sequence between the first two active site residues that is identical 
to ALDOB is particularly interesting since it is in a region that contributes to the distinct 
properties of ALDOA and ALDOB [72-74].   Further studies will be necessary to assess the 
catalytic properties of the ALDOA-related isozymes.  Although the potential for metabolizing 
fructose via an ALDOB-like isozyme would appear to be beneficial for sperm, fructose is 
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apparently unable to support hyperactivated sperm motility and in vitro fertilization in the 
mouse [75-77].  It is interesting to note that most of the isozyme-specific residues identified 
for the aldolases are not within hydrogen bonding distance of the active site and are 
localized on the surface where they may exert long-distance conformational effects or 
mediate tissue-specific protein interactions [45].  Several of these residues are localized in 
the flexible C-terminal region that has been shown to contribute to differences between the 
aldolase isozymes [74, 78].  Multiple unique residues are present within the C-terminal 
regions of both Aldoart1 and Aldoart2 where they could contribute to novel enzymatic 
properties.  
Both ALDOART1 and ALDOA_V2, the larger aldolase isozymes, are present in 
purified fibrous sheath preparations.  Like GAPDHS [8], these isozymes have distinctive N-
terminal extensions that could mediate targeting to the fibrous sheath and/or tight binding to 
this cytoskeletal structure.  Aldolase functions as a tetramer, and heterotetramers of ALDOA 
with ALDOB or ALDOC have been identified in various tissues [37, 69].  Our proteomic 
analyses did not detect ALDOA in mouse sperm.  The restricted expression of the newly 
identified ALDOA-related isoforms in spermatids suggests that functional tetramers 
containing one or more of these isoforms are formed late during spermatogenesis and are 
tethered to the forming fibrous sheath by the N-terminal extensions of ALDOART1 and 
ALDOA_V2.  Binding of aldolase tetramers to an insoluble structure such as the fibrous 
sheath could affect their conformation and modulate their kinetic properties.    
Compartmentalization of the glycolytic enzymes in the principal piece may facilitate 
energy production along the entire length of the sperm flagellum, providing a localized 
supply of ATP to the dynein ATPases in the axoneme to maintain motility.  Enzymatic 
complexes are common in nature and direct binding between glycolytic enzymes has been 
suggested [79-81].  Recent proteomic studies identified multiple glycolytic enzymes in the 
flagella of  Chlamydomonas reinhardtii, including some that are associated with the 
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axoneme [82, 83].  These studies suggest that there may be a more general requirement for 
glycolytic enzyme localization and ATP production in flagella.  Some glycolytic enzymes, 
including ALDOA and GAPDH, are co-localized at the Z-discs and M-lines in Drosophila 
flight muscles [84, 85].  Flies that lack glycerol-3-phosphate dehydrogenase lose the ability 
to fly and the localization of both ALDOA and GAPDH in the flight muscle, providing another 
link between the co-localization and function of glycolytic enzymes [84, 85].  Similarly, the 
co-localization of glycolytic enzymes in the principal piece of mammalian sperm may result 
in higher catalytic activity to support sperm motility.   
There is ample evidence that the glycolytic pathway is extensively modified during 
mammalian spermatogenesis and is required for sperm function and male fertility.  This 
study indicates that both retrotransposition and alternative splicing are responsible for the 
restricted expression of three novel ALDOA-related isoforms during the haploid phase of 
mouse spermatogenesis.  All three are present in mature sperm and two isoforms with N-
terminal extensions are tightly bound to the fibrous sheath.   Further studies to assess the 
functional properties of the ALDOA-related isozymes and other sperm-specific glycolytic 
enzymes may provide new insights regarding potential genetic causes of infertility and the 
rational design of contraceptives.  In addition, detailed genomic and molecular analyses of 
novel glycolytic enzymes in the male germline offer a promising approach to identify 
elements that regulate gene expression during spermatogenesis and to increase our 
understanding of the causes underlying the differential rates and non-random locations of 
retrotransposition.  
The fate of most retrotransposition events is to fade into evolutionary history as 
pseudogenes.  It is, therefore, remarkable that Aldoart1 and Aldoart2 show a striking 
combination of negative selection at all active site residues (Fig. 2.4), convergent evolution 
at isozyme-specific residues (Fig. 2.4), and positive selection at many other amino acids 
(Fig. 2.2 and Fig. 2.3B).  Since these two retrogenes are only expressed during the final 
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stages of spermatogenesis and their products are present in sperm, we hypothesize that 
reproductive performance is the most likely force that has shaped their evolution. 
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Figure 2.1 
 
 
 
 
Figure 2.1.  Genomic organization and mRNA structure of the mouse Aldoa gene and 
related retrogenes.  The Aldoa gene on chromosome 7 is shown at the top, with numbers 
indicating the lengths of exons (boxes) and introns (lines).  Aldoart1 and Aldoart2 are 
intronless retrogenes on chromosomes 4 and 12, respectively.  Coding sequences are 
indicated by white and black boxes, with black boxes representing novel N-terminal 
sequences.  Boxes with diagonal lines denote homologous UTRs in Aldoa, Aldoart1 and 
Aldoart2.  Boxes with vertical or horizontal lines denote UTR sequences found only in 
Aldoart1 or Aldoart2, respectively.  The lengths of novel regions are noted.    
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Figure 2.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.  Phylogenetic relationships between aldolase genes and retrogenes.  The 
tree depicts the relationships between orthologs in mouse (Mm), rat (Rn), human (Hs) and 
chimpanzee (Pt), and is based on a consensus cladogram from three consensus trees 
obtained by three different phylogenetic methods (Neighbor, Dnapars and Dnam).  The 
figure shows the number of times out of 100 that a branch is observed in each method for 
the less well-supported branch.  All remaining branches are supported by more than 90% of 
trees in all three methods. Triangles denote the primate/rodent split.  Open circles represent 
the split between the human and chimpanzee lineages.  Filled circles represent the split 
between the mouse and rat lineages.  The length of the branches is proportional to the ones 
obtained in a representative tree using the Neighbor  method. 
  48
Figure 2.3 
 
 
 
 
 
 
 
 
Figure 2.3.  Phylogenetic relationships between novel N-terminal sequences in the 
aldolase A family.  (A) This diagram shows the two exons that generate the novel Aldoa 
splice variant (Aldoa_v2).  Exon 2 includes a fragment of the 5’-UTR (shown as a grey box) 
and 144 nucleotides that encode the first 48 amino acids of the N-terminal extension of 
ALDO_V2 (black box).  Exon 3 contains 21 nucleotides that encode the remaining 7 amino 
acids of the novel N-terminal sequence (black box).   (B) The tree depicts the relationships 
between homologous sequences encoding the N-terminal extensions of Aldoa_v2 and 
Aldoart1.  The tree is based on a consensus cladogram from three consensus trees 
obtained by three different phylogenetic methods (Neighbor, Dnapars and Dnaml).  The 
figure also shows the number of times out of 100 that a branch is observed in each method 
for the two less well-supported branches.  All remaining branches are supported by more 
than 90% of trees in all three methods.  (C) Conservation of the amino acid sequence of the 
N-terminal extensions across species.  Amino acid alignment of the N-terminal extension of 
ALDOA_V2 in mouse (Mm), rat (Rn), macaque (Mf), chimpanzee (Pt), and human (Hs), and 
mouse ALDOART1 (Art1).  An asterisk (*) denotes residues that are identical while a dash (-
) denotes the absence of that residue. 
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Figure 2.4 
 
 
 
Figure 2.4.  Amino acid alignment for the mouse aldolase genes.  Asterisks (*) denotes 
identical amino acid residues.  ALDOA_V2 and ALDOART1 have novel N-terminal 
extensions.  Boxed amino acids denote active site residues, which are conserved in all 
members of the gene family.  Amino acids that are unique to ALDOART1 or ALDOART2 are 
highlighted in black with white lettering.  Additional residues in each retrogene that match 
ALDOB or ALDOC rather than ALDOA are highlighted in grey.  Three isozymes-specific 
residues in ALDOART1 that match ALDOB are noted by black arrows.   
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Figure 2.5 
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Figure 2.5.  Restricted expression of Aldoart1 and Aldoart2 during the late stages of 
spermatogenesis.  (A)  Diagram of the RT-PCR approach used to distinguish Aldoa-related 
transcripts.  Arrows denote a single primer set which amplified a 530 bp product from 
Aldoa/Aldoa_v2, Aldoart1 and Aldoart2 cDNAs.  HaeIII digestion of these products produced 
distinct fragments that were resolved by electrophoresis on 5% acrylamide gels.  (B)  The 
expected fragments were amplified from DNA positive controls, including an Aldoa cDNA 
subclone and BAC (bacterial artificial chromosome) clones for the intronless retrogenes 
(clone RP24-191C1 for Aldoart1, clone RP23-63H11 for Aldoart2).  RT-PCR of total RNA 
samples detected Aldoart1 and Aldoart2 transcripts in testis, but not in other tissues.  
Transcripts from the Aldoa gene (Aldoa_v1 or Aldoa_v2) were present in all tissues 
examined.  RNAs for the second testis lane and remaining tissues were isolated from 
(C57BL/6J x A/J)F1 mice, while RNAs for the first testis lane, testes from juvenile animals 
between 8 and 22 day of age (8, 18, 20, 22) and isolated testicular cells were from CD-1 
mice.  During postnatal development, Aldoart1 and Aldoart2 are first expressed in the testis 
at 20 days of age.  Semi-quantitative RT-PCR conditions were used to compare transcript 
levels in isolated pachytene spermatocytes (P), round spermatids (R), condensing 
spermatids (C) and Sertoli cells.  (C) Analysis of the semi-quantitative RT-PCR products by 
densitometry.  Bars represent mean densities ± SEM calculated from 3-6 replicated PCR 
reactions.   
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Figure 2.6 
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Figure 2.6.  Restricted expression of Aldoa_v2 in testis.  (A) Diagram of the RT-PCR 
strategy used to distinguish between Aldoa, Aldoa_v2, Aldoart1.  Arrows denote a single 
primer set which amplified 350, 193 and 353 bp products from Aldoa_v2, Aldoa, and 
Aldoart1, respectively.  HaeIII digestion cleaved only the Aldoa_v2 product, resulting in 
distinct bands for each transcript on 5% acrylamide gels.  (B) This strategy detected 
Aldoa_v2 transcripts only in testis (CD-1 testis in the first RNA lane, other tissue RNAs from 
(C57BL/6J x A/J)F1 mice).  (C) Testis RNAs from juvenile CD-1 mice (8-34 days of age) 
were also analyzed to compare the appearance of Aldoa_v2 and Aldoart1 transcripts during 
postnatal development.  RNAs were isolated from pooled testes and RT-PCR was repeated 
three times to confirm reproducibility.  Control DNAs for the assays in (B) and (C) included 
an Aldoa cDNA subclone and a BAC clone for Aldoart1 (clone RP24-191C1).  
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Figure 2.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7.  Proteomic and Western analyses identify novel ALDOA-related proteins in 
mouse sperm.  Proteins in the soluble fraction following sonication (soluble), the tail pellet 
(tail P), and isolated fibrous sheaths (FS) were separated by SDS-PAGE.   Protein from 106 
sperm was loaded in the soluble and tail P lanes, while the FS lane contains protein from 
107 sperm.  (A) Bands indicated by arrows on this representative Sypro Ruby-stained gel 
were isolated and analysed by mass spectrometry.  MALDI identified the bands as aldolase-
A related proteins.  LC-MALDI identified peptides specific for ALDOART2 in the soluble 
~39,000 molecular weight protein and peptides specific for ALDOA_V2 and ALDOART1 in 
the ~50,000 molecular weight band enriched in the tail P and FS fractions (see 
Supplemental Figs S1-S3).  (B) Western analysis of the three fractions using a polyclonal 
antibody raised against rabbit skeletal muscle aldolase.   
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Figure 2.8 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8.  Larger ALDOA-related isoforms are first translated in condensing 
spermatids and are conserved in mouse, rat and human sperm.   Following SDS-PAGE, 
Western blots were probed with a polyclonal antibody raised against rabbit skeletal muscle 
aldolase.  Equal protein loads were confirmed by Coomassie blue staining of the blots (not 
shown).  (A)  A ~50,000 molecular weight ALDOA-related band was detected in mouse 
sperm, but not in eight somatic tissues including skeletal muscle (S Muscle) and small 
intestine (S Intestine).  (B) The larger ALDOA-related band was also detected in testis and 
condensing spermatids (C), but not in Sertoli cells, spermatogonia (Gonia), pachytene 
spermatocytes (P) or round spermatids (R).  (C)  A larger ALDOA-related band is present in 
mouse (Mm), rat (Rn) and human (Hs) sperm. 
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Table 2.1.  Total number of aldolase ESTs in selected tissues and isolated testicular cells  
 Selected Tissues Isolated Testicular Cells 
 All Brain Liver Musc Testis L S A B P R 
Aldoc >100 >100 1b 3b 0 0 0 0 0 0 0 
Aldob >100 0 >100 21 0 0 0 0 0 0 0 
Aldoa >100 >100 12 >100 8 1b 8c 0 3 1 0 
Aldoa_v2a 17 0 0 0 1 0 0 0 0 0 0 
Aldoart1 10 0 0 0 7 0 0 0 0 0 2 
Aldoart2 33 0 0 0 27 0 0 0 0 0 3 
 
ESTs were analyzed from selected mouse tissues and isolated testicular cells, including 
muscle (Musc), Leydig cells (L), Sertoli cells (S), type A spermatogonial (A), type B 
spermatogonial (B), pachytene spermatocytes (P) and round spermatids (R).  ESTs from 
pooled libraries were excluded in this analysis.  
a
 refers to exon 2           
b
 BLAST hits from cell lines         
c
 BLAST hits from primary Sertoli cell cultures 
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Table 2.2.  Expression frequency of Aldoa-related genes  
  Testis Leydig Sertoli B Gonia Pachytene R Spermatid 
Aldoa 0.8 (0.3) 11.4 (11.4) 7.5 (2.6) 3.7 (2.1) 1.1 (1.1) 0.0 
Aldoart1 0.6 (0.2) 0.0 0.0 0.0 0.0 5.0 (3.5) 
Aldoart2 2.3 (0.4) 0.0 0.0 0.0 0.0 7.5 (4.3) 
 
Data are presented as the number of ESTs for each gene per 10,000 sequenced ESTs in 
libraries derived from testis and isolated cells including type B spermatogonia (B Gonia), 
pachytene spermatocytes (Pachytene) and round spermatids (R Spermatid).  Standard 
errors are shown in parentheses.  
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Table 2.3.  Aldoa-related gene expression in other tissues 
  Tissue Number of ESTs Frequencya  
Aldoart1 Unknown 1 0.5 (0.5) 
Aldoart2 Spleen 3 0.4 (0.2)  
 
a Number of ESTs for each gene per 10,000 sequenced ESTs in each library, with standard 
errors in parentheses  
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Supplemental Figure 2.1 
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Supplemental Figure 2.1.  Mass spectrometry (MS) identifies ALDOART2 as a soluble 
protein in mouse sperm.  Proteins in the soluble fraction following sonication were 
concentrated and separated on SDS-polyacrylamide gels.  The band corresponding to the 
~39,000 molecular weight aldolase isoform was subjected to in-gel digestion followed by LC-
MALDI analysis.  (A)  A representative MS/MS spectrum showing fragmentation products 
from the m/z 2258.22 precursor ion.  The m/z 2258 ion corresponds to the peptide 
GVVPLAGTNGETTTQGLDDLSGR, which is unique to the ALDOART2 isoform.  Amino-
terminal (b) and carboxyl-terminal (y) ions are indicated.  (B) Summary of MS/MS data for all 
peaks unique to ALDOART2 that were analyzed in the LC-MALDI experiments.  (C)  
Summary of additional peptide masses (within 100 ppm) found in the LC-MALDI 
experiments that could be derived from the ALDOART2 (ART2) isoform.  Note that some 
peptides could be derived from more than one isoform due to the degree of homology 
between ALDOART2, ALDOA (A) and ALDOART1 (ART1). 
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Supplemental Figure 2.2 
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Supplemental Figure 2.2 
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Supplemental Figure 2.2.  Mass spectrometry identifies ALDOA_V2 in mouse sperm.  
Following the separation of sperm tail or fibrous sheath proteins by SDS-PAGE, LC-MALDI 
was used to analyze the 50,000 molecular weight band.  (A)  A representative MS/MS 
spectrum showing fragmentation of the peak at m/z 3043.40.  As in Supplemental Fig. 1, b 
and y ions from this ALDOA_V2 peptide are labeled.  (B) A representative MS/MS spectrum 
from the m/z 1283.61 precursor ion, which is derived from the unique region of the 
ALDOA_V2 N-terminal extension.  B and y ions are labeled.  Y ions labeled -64 result from 
the loss of HSOCH3 from the oxidized methionine.  (C)  Summary of the MS/MS spectra 
obtained in our LC-MALDI experiments that could be derived from ALDOA_V2.  (D)  
Summary of additional peptide masses (within 100 ppm) observed in LC-MALDI 
experiments that could be derived from ALDOA_V2 (A_V2).  Peptides in bold are derived 
specifically from the N-terminal extension of ALDOA_V2.  Peptides in normal typeface are 
found in both ALDOA and ALDOA_V2, but are attributed to ALDOA_V2 because they were 
isolated from the ~50,000 molecular weight band.  Again, due to the high level of sequence 
identity between ALDOA_V2, ALDOART1 (ART1) and ALDOART2 (ART2), certain peptides 
could be derived from more than one isoform. 
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Supplemental Figure 2.3 
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Supplemental Figure 2.3.  Mass spectrometry identifies ALDOART1 in mouse sperm.  
Following the separation of sperm tail or fibrous sheath proteins by SDS-PAGE, LC-MALDI 
also identified ALDOART1 in the 50,000 molecular weight band.  (A)  A representative 
MS/MS spectrum from the m/z 1506.68 precursor ion.  Fragment ions in this spectrum can 
correspond to b and y ions from the GILAADESIGMGNR peptide, which is unique to the 
ALDOART1 isoform.  (B)  MS/MS spectrum from the m/z 1226.68 precursor ion.  Fragment 
ions in this spectrum correspond to b and y ions from the QDVSIFNMTR peptide unique to 
the N-terminal extension of ALDOART1.  (C)  Summary of MS/MS results for peptides 
unique to the ALDOART1 isoform.  D.  Summary of additional peptide masses found in our 
LC-MALDI experiments that correspond (within 100 ppm) to ALDOART1 (ART1) peptides.  
For brevity, masses that could be derived from multiple aldolase isoforms are not repeated 
from Figure 2D. 
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Supplemental Table 2.1.  Mouse aldolase A gene, retrogenes and pseudogenes 
Chromosome Start End  Status 
7 126586384 126590331 Gene 
4 72337488 72339071 Retrogene 
12 56483411 56484712 Retrogene 
X 152721872 152723250 Pseudogene 
6 39772630 39774080 Pseudogene 
3 57450178 57451543 Pseudogene 
X 153493899 153495466 Pseudogene 
10 29773608 29774775 Pseudogene 
X 128234278 128235510 Pseudogene 
X 114814571 114815824 Pseudogene 
X 54006718 54007872 Pseudogene 
9 79132459 79133400 Pseudogene 
X 127515370 127516260 Pseudogene 
14 55135918 55136753 Pseudogene 
9 79131982 79132447 Pseudogene 
2 83195325 83195668 Pseudogene 
4 112228575 112228962 Pseudogene 
1 92957529 92957664 Pseudogene 
Assembly: NCBI m36, December 2005; Genebuild: Ensembl, April 2006; Database version: 
42.36c  
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CHAPTER 3 
KINETIC PROPERTIES OF SPERMATOGENIC-CELL SPECIFIC 
ALDOLASE A ISOZYMES 
 
Abstract 
Fructose-1,6-bisphosphate (FBP) aldolase, or aldolase, is a metabolic enzyme which 
cleaves FBP during glycolysis.  Aldolase also functions during gluconeogenesis and 
fructose metabolism.  Glycolysis is modified during mouse spermatogenesis through the 
expression of spermatogenic-cell specific enzymes, including three novel aldolase A 
(ALDOA)-related proteins:  ALDOA_V2, ALDOART1 and ALDOART2.  Both ALDOA_V2 and 
ALDOART1 possess N-terminal extensions that are not present in ALDOA or other 
aldolases.  Conserved spermatogenic-cell specific expression of ALDOA_V2 across species 
supports the functional importance of this isozyme.  Here we report high levels of ALDOA 
FBP activity in insoluble fractions of mouse sperm. Amino acid alignment and preliminary 
three-dimensional modeling suggests that ALDOART1 and ALDOART2 may have unique 
catalytic properties.  Recombinant ALDOA_V2, ALDOART1, and ALDOART2 do not form 
tetramers when expressed in E. coli, which may contribute to dramatically reduced FBP 
activity as compared to ALDOA.  Understanding energy metabolism in sperm is important in 
the context of male fertility.  Previous studies have identified glycolysis as the primary 
source of ATP production required for sperm motility and male fertility.  Therefore, defining 
the kinetic properties of spermatogenic-cell specific aldolase A isozymes may provide 
insights on the regulation of sperm metabolism. 
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Introduction 
Fructose-1,6-bisphosphate aldolase, or aldolase, is an enzyme which catalyzes the 
cleavage of fructose-1,6-bisphosphate (FBP) in the glycolytic pathway, forming two triose 
phosphates.  Since aldolase is a reversible enzyme, it is known to participate in the reverse 
reaction of glycolysis, gluconeogenesis.  Aldolase also cleaves fructose-1phosphate (F1P) 
during fructose metabolism, or fructolysis.   
A spectrophotometric assay measures aldolase activity through the addition of 
exogenous enzyme to a reaction mixture containing the FBP substrate, two coupling 
enzymes (triose phosphate isomerase and α-glycerophosphate dehydrogenase), and β-
NADH (Figure 3.1A).  When aldolase cleaves FBP, β-NADH is oxidized to β-NAD in the 
coupled reaction catalyzed by α-glycerophosphate dehydrogenase.  The loss of β-NADH is 
monitored at 340 nm, reflecting increases in aldolase activity [1, 2].   
A hyperbolic saturation curve is created by measuring the activity of a particular 
enzyme over varying substrate concentrations (Figure 3.1B).  The Km and Vmax of the 
enzyme is calculated from this curve.  Vmax is the enzyme’s maximum specific activity, while 
Km is the concentration of substrate where the Vmax is ½.  A small Km value means an 
enzyme requires a small amount of substrate to reach saturation, while a large Km indicates 
that an enzyme reaches maximum velocity at high substrate concentrations.   
Aldolase is encoded by a family of genes in vertebrates, Aldoa, Aldob, and Aldoc.  
Each aldolase enzyme exhibits unique expression patterns and enzymatic properties.  Aldoa 
is expressed ubiquitously and is highly expressed in skeletal muscle, Aldob is expressed in 
the liver and kidney, and Aldoc is expressed primarily in the nervous system [3, 4].  The 
aldolases function as tetramers [5], although studies using recombinant proteins have 
confirmed active dimers and monomers [6].  In tissues where more than one aldolase 
isozyme is expressed, tetramers of multiple aldolase isozymes, or heterotetramers, form [4].    
  
 
77
Studies of aldolases purified from different tissues demonstrated unique kinetic 
properties of ALDOA, ALDOB, and ALDOC [3, 7-11].  ALDOA purified from rabbit skeletal 
muscle or brain possesses the highest Vmax for FBP, a very high Km for F1P (only active at 
high concentrations), and a high FBP/F1P ratio, indicating that ALDOA preferentially 
catalyzes glycolysis over gluconeogenesis and fructolysis (Table 3.1, adapted from [8]).  
ALDOB has greater catalytic efficiency for gluconeogenesis and fructolysis, as shown by its 
lower Vmax for FBP, higher Vmax for F1P and lower FBP/F1P ratio compared to ALDOA.  It is 
expressed in the liver and kidney, tissues which promote both reactions. Finally, ALDOC 
possesses intermediate FBP and F1P activity when compared to ALDOA and ALDOB and 
has a primary glycolytic role.   
We previously identified two additional Aldoa-like genes in the mouse genome, 
Aldoart1 and Aldoart2 [12].  Both Aldoart1 and Aldoart2 encode proteins that are expressed 
only in haploid cells during mouse spermatogenesis.  Analysis of the Aldoart1 sequence 
provided evidence for an alternative splice variant (Aldoa_v2) of aldolase A.  Aldoa_v2 is 
expressed only during spermatogenesis and encodes a protein present in mouse, rat and 
human sperm.  Both Aldoa_v2 and Aldoart1 encode N-terminal extensions that appear to be 
important for tight binding to the fibrous sheath and compartmentalization with other 
glycolytic enzymes in the principal piece of the sperm flagellum. 
In this study we measured the catalytic activity of spermatogenic cell-specific 
aldolase A isozymes in vivo and in vitro.  Preliminary three-dimensional modeling draws 
attention to unique structural differences in the outer face and near the substrate binding 
pocket of these isozymes, suggesting unique binding and catalytic properties.  To assess 
the kinetic properties of each isozyme, we expressed recombinant forms of each protein, 
monitored tetramer formation and measured FBP catalytic activity.  We hypothesize that 
these novel aldolase A isozymes may have distinctive catalytic properties that promote 
enhanced glycolytic activity in sperm.     
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Methods 
Isolation of mouse sperm from cauda epididymis 
Outbred CD-1 mice were obtained from Charles River (Raleigh, NC).  All procedures 
involving animals were approved by the University of North Carolina at Chapel Hill Animal 
Care and Use Committee and conducted in accordance with the Guide for the care and Use 
of Laboratory Animals (Institute for Laboratory Animal Research, National Academy of 
Sciences).   
Mouse sperm was collected as previously described [12].  Briefly, clipped cauda 
epididymis were incubated for 15 minutes at 37 °C in p hosphate-buffered saline with 
protease inhibitors (PBS + PI) containing 140 mM NaCl, 10 mM phosphate buffer (pH 7.4) 
and Complete protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany).  Sperm 
were washed in PBS+PI to remove debris and counted to determine the final concentration.    
 
SDS-PAGE analysis of mouse sperm protein lysates 
In order to measure activity of endogenous ALDOA-related proteins, sperm lysates 
were prepared using a published protocol [13].  Proteins were extracted in HEM1 buffer 
(50mM HEPES, 5mM EDTA, 4mM β-mercaptoethanol, 0.05M sodium phosphate, 0.1% TX-
100, pH 7.4) containing Complete protease inhibitor cocktail.  Cauda epididymal sperm were 
resuspended in HEM1 buffer at a concentration of 1 x 105/µL and sonicated on ice with a 
pre-chilled probe for six 5-second intervals at 40% output using a Branson Sonifier Cell 
Disruptor 185 (Danbury, CT).  An aliquot was taken for the “lysate” sample.  The sample 
was then centrifuged at 16,000 x g for 10 minutes at 4°C.  The supernatant was removed, 
and the pellet was resuspended in HEM1 extraction buffer.  The catalytic activity of samples 
was measured. 
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 Protein samples were heated at 95°C in 2X sample load ing buffer (2% SDS, 100mM 
DTT, 125 mM Tris-HCl pH 6.8, 18% glycerol, 0.002% Bromophenol blue) containing 50mM 
TCEP reducing agent (tris-(2-carboxyethyl) phosphine, Pierce Biotechnology, Rockford, IL), 
and resolved by 10% SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis).  The BenchmarkTM protein ladder (Invitrogen, Carlsbad, CA) was included 
on these gels.  Protein loads were adjusted to 5 x 105 cell equivalents for the lysate and 
pellet samples and 7.5 x 105 cell equivalents for the supernatant sample.  Following 
electrophoresis, samples were electrophoretically transferred to Immobilon-P PVDF 
(polyvinylidene fluoride) membranes (Millipore Corp, Bedford, MA).  Approximate equal 
loading of samples was confirmed by 0.1% Coomassie blue R250 staining in 45% methanol 
and 10% acetic acid.  Membranes were destained and rinsed with TBS-T (140mM NaCL, 
3mM KCl, 0.05% Tween-20, 25mM Tris-HCl, pH 7,4), following by incubation in blocking 
buffer (5% nonfat dry milk in TBS-T) overnight at 4°C.  Immunodetection of aldolase was 
performed at room temperature.  Membranes were incubated with a polyclonal anti-aldolase 
A primary antibody (Polysciences, Warrington, PA) at a dilution of 1:2,000 in blocking buffer 
for 1 hour at room temperature.  Following three 15-minute washes in TBS-T, membranes 
were incubated with secondary antibody (affinity-purified horseradish peroxidase-conjugated 
rabbit anti-goat IgG, KPL, Gaithersburg, MD) at 1:10,000 for 30 minutes at room 
temperature in blocking buffer.  After three 15-minute TBS-T washes, immunoreactive 
proteins were detected by enhanced chemiluminescence using SuperSignal West Pico 
substrate (Pierce Biotechnology, Rockford, IL) with HyBlot CL autoradiography film (Denville 
Scientific, Metuchen, NJ).      
 
Preliminary three-dimensional protein structure modeling 
Modeling data was obtained using previously described structures for rabbit aldolase 
A, since the structure for mouse aldolase A has not been solved.  Mouse aldolase A has six 
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residues that are different when compared to rabbit aldolase A.  Of these six residues, two 
are unique to ALDOART1 and ALDOART2 when compared to mouse ALDOA.  Therefore, 
we marked these two residues as unique and the remaining four residues as identical since 
they are found in all mouse aldolase A isozymes.   In addition to these two unique residues, 
we also marked 15 unique residues in ALDOART1 and 17 unique residues in ALDOART2.  
The aldolase monomer model used was 3B8D with a resolution of 2.0 Å [14].  For the 
aldolase tetramer, we used the 1ZAL structure, with a resolution of 1.8 Å [15].   
Modifications were made using PyMOL (DeLano Scientific, Palo Alto, CA).   
 
Expression of recombinant ALDOA-like proteins 
We used testis cDNA and cDNA from condensing spermatids [12] to subclone Aldoa, 
Aldoa_v2, Aldoart1, and Aldoart2 using primer-based PCR amplification with restriction 
enzyme sites (EcoRI, XhoI, and SalI) for insertion into an expression vector.  For Aldoa, the 
primers were:  forward 5’GAATTCATGCCCCACCCATA 3’, reverse 
5’CTCGAGTTCAATAGCAAGTGG3’.  For Aldoa_v2, the primers were:  forward 
5’GAATTCATGGCAACGCGCAG3’, reverse 5’CTCGAGTTCAATAGCAAGTGG3’.  For 
Aldoart1, the primers were:  forward 5’CGGAATTCATGGCAACGCACAGGCA3’, reverse 
5’AGCGTCGACACATGAGGGCA3’.  For Aldoart2, the primers were:  forward 
5’GAATTCATGTCTTACCCCTACC3’, reverse 5’CTCGACACCTCTGCTCAGTA3’.    
Full-length amplified products and open reading frames were confirmed by DNA 
sequencing (UNC-Genome Analysis Facility, Chapel Hill, NC).   These PCR products were 
subcloned into a bacterial expression vector (pGEX4T-1, GE Healthcare Life Sciences, 
Piscataway, NJ) containing an N-terminal GST sequence that can be cleaved using 
thrombin protease.  Constructs were transformed and expressed in E. coli, using BL21 
competent cells (Novagen, Gibbstown, NJ).  For protein expression, single colonies were 
selected and grown in a 25 ml LB-ampicillin (10g Tryptone, 5g Yeast Extract, 10g NaCl, 50 
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µg/mL ampicillin) overnight at 37°C, shaking at 210 RP M.  This culture was transferred to 
225 ml of LB-ampicillin and grown for 1 hour.  Once cells reached a density measured as 
0.6 at 600 nm, they were induced with 0.1mM IPTG (isopropyl-beta-D-
thiogalactopyranoside) for 4 more hours.  Cells were pelleted by centrifugation at 6000 x g, 
4°C.   
To isolate protein, cells were resuspended in PBS (137mM NaCl, 2.7 mM KCl, 4.3 
mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4) + Complete protease inhibitor cocktail, followed by 
sonication on ice with a pre-chilled probe for six 5-second intervals at 40% output using 
Branson Sonifier Cell Disruptor 185 (Danbury, CT).  Lysates were treated with 0.1% Triton 
X-100 on ice for 1 hour, and then cleared by centrifugation at 16,000 x g at 4°C.  Washed 
and pre-swelled Glutathione Sepharose 4B beads (GE Healthcare Life Sciences, 
Piscataway, NJ) at 50% in PBS +PI were added to cleared lysates and incubated overnight 
at 4°C with rocking.  Beads were pelleted and washed three times using PBS alone at 4°C, 
1,000 x g, for 5 minutes.  Thrombin protease (from bovine plasma, Sigma-Aldrich, St. Louis, 
MO) diluted in PBS was added (at a concentration of 1unit/25µL) directly to the beads to 
cleave the GST tag and incubated with rocking for three days at 4°C.  Cleaved recombinant 
aldolase A proteins were separated from beads by centrifugation at 1,000 x g for 5 minutes.  
Beads were washed once with PBS.  Both fractions were kept for analysis.  Protein 
concentrations were calculated as previously described [6, 16-20] by measuring the 
absorbance at 280 nm and calculating the extinction coefficient for each ALDOA-related 
protein using the ProtParam tool on ExPASy (Swiss Institute of Bioinformatics, Switzerland, 
http://ca.expasy.org/tools/protparam.html).  The following extinction coefficients were 
calculated:  0.874 (ALDOA), 0.762 (ALDOA_V2), 0.725 (ALDOART1) and 0.911 
(ALDOART2).  Purity of recombinant proteins and equal loading was confirmed by 10% 
SDS-PAGE followed by Coomassie R250 staining (described above).     
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Native PAGE analysis of tetramer formation 
 Recombinant proteins were diluted in 2X native sample loading buffer (125 mM Tris-
HCl pH 6.8, 18% glycerol, 0.002% bromophenol blue) and resolved by native PAGE.  Equal 
protein amounts (0.5 µg) were resolved on precast 4-15% gradient gels (Bio-Rad 
laboratories, Hercules, CA) at 100V for 4 hours on ice.  Gels were fixed for 1 hour in 45% 
methanol, 10% acetic acid, followed by staining in Sypro Ruby (Molecular Probes, Eugene, 
OR) overnight.  Gels were destained in 10% methanol, 7% acetic acid (2 x 30 minutes).  All 
staining procedures were done at room temperature with gentle agitation.  Gels were 
visualized using UV illumination.            
 
Measuring aldolase FBP activity 
Catalytic activity of endogenous and recombinant proteins was measured using an 
enzymatic assay for aldolase (Sigma-Aldrich, St. Louis, MO).  The presence of either 106 
sperm equivalent of protein or 100ng of active aldolase in combination with 2.6mM fructose-
1,6-bisphosphate (Sigma F-6803), α-glycerophosphate dehydrogenase (α-GDH), triose 
phosphate isomerase (TPI), and 29 mM β-NADH (Sigma N-8129) will oxidize β-NADH to β-
NAD (measured at A340nm, Figure 3.1).  α-GDH and TPI were added as a mixture at 25 
units/mL (Sigma G-1881).  All reagents were purchased from Sigma-Aldrich (St. Louis, MO) 
and all solutions were prepared in 100mM Tris-HCl, pH 7.4.  
To correct for background activity, we refrained from adding the enzyme to each 
reaction and allowed for the reaction to reach zero activity (approximately 10 minutes).  We 
then added the enzyme and measure the change (slope) in β-NADH absorption over 10 
minutes.  Kinetic parameters were calculated by measuring the velocity (slope) of the 
enzyme during the linear phase of the curve at various substrate concentrations.  To 
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calculate the Km and Vmax we used the Michaelis-Menten equation (Y=VmaxX/(Km+X), where 
X is the substrate concentration and Y is the velocity) in GraphPad Prism4 (La Jolla, CA).   
 
Results 
Fructose-1,6-bisphosphate activity is found in insoluble fraction of sperm lysate 
Previous studies of purified bovine sperm aldolase demonstrated maximum specific 
activity in a Triton X-100 and β-mercaptoethanol-containing buffer [13].  Based upon this 
data, we extracted mouse sperm using the same buffer and conditions.  We detected 
aldolase isozymes with two molecular weights in both the supernatant and pellet fraction 
(Figure 3.2A).  Our proteomic analyses (Chapter 2) indicate that the smaller molecular 
weight immunoreactive band contains ALDOART2, while the larger molecular weight band 
contains ALDOA_V2 and ALDOART1.  The pellet fraction contains more of the larger 
molecular weight ALDOA-related proteins.   
By measuring activity in the total lysate and the fractionated samples, we see that 
the kinetic values for FBP aldolase activity in the supernatant fraction are similar to the 
previously described values for purified bovine sperm aldolase (Table 3.2 and [13]).  
However, most of the endogenous aldolase FBP activity in the total lysate is found in the 
insoluble pellet fraction (Figure 3.2B), where ALDOA_V2 and ALDOART1 are found.  These 
data also match studies using bovine sperm aldolase A [13].  Since the sperm lysates and 
fractions contain multiple ALDOA isozymes, it would be advantageous to measure activity of 
the individual isozymes. 
   
Individual spermatogenic-cell specific aldolase A isozymes possess amino acid residues 
which may confer unique activity 
Proteomic analysis indicates that mouse sperm lysates contain at least three, and 
possibly four, ALDOA-related isozymes [12].  ALDOA_V2 is also expressed in rat and 
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human sperm [12].  Amino acid alignment of all ALDOA-related proteins expressed in testis 
demonstrates conservation of all known active site residues [12].  The only difference 
between ALDOA and ALDOA_V2 is the presence of a 54 amino acid N-terminal extension in 
ALDOA_V2 [12].  Although ALDOART1 and ALDOART2 are 95% identical to ALDOA, each 
has several residues that are more like ALDOB than ALDOA  (green in Fig. 3.3) and three of 
these have been identified as isozyme-specific residues (arrows, Figure 3.3 and [21]).  
ALDOB catalyzes gluconeogenesis (the reverse reaction of glycolysis) and fructolysis more 
efficiently than ALDOA or ALDOC (Table 3.1, [8]).  Preliminary modeling data of aldolase 
monomers shows the position of unique residues (red) and ALDOB-like residues (light blue) 
in ALDOART1 and ALDOART2, located to the outside of the protein structure or 
surrounding the substrate binding pocket (dark blue, Figure 3.4, modified from [22]).  Unique 
peripheral amino acid residues may participate in proper localization in the sperm flagellum.  
Residues that are located closer to the active site, including the three ALDOB isozyme-
specific residues in ALDOART1, may contribute to distinct catalytic activity.  Differences in 
amino acid residues may direct unique localization and/or catalytic function of isozymes.   
  
Recombinant ALDOA proteins may not form tetramers and have reduced activity 
To determine the catalytic activity of ALDOA-related proteins in mouse sperm, we 
expressed recombinant forms of each isozyme in E. coli.  In vivo, the aldolases function as  
tetramers, and heterotetramers have been observed in tissues that express multiple 
isozymes  [4].  We measured activity using GST-tagged ALDOA and ALDOA_V2 (Figure 
3.5).  In general, ALDOA expresses at much higher levels in E. coli than the sperm ALDOA 
isozymes.  Despite conservation of all active site residues and 100% amino acid sequence 
identity with exception to the N-terminal extension, ALDOA_V2 FBP activity was lower than 
ALDOA activity.  The Vmax was lower and the Km was dramatically higher for GST-
ALDOA_V2 (Table 3.3).  Since aldolase functions as a tetramer, we hypothesized that the 
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presence of the GST-tag might interfere with tetramer formation of any GST-ALDOA-related 
proteins.  In fact, the N-terminal of ALDOA extends into the center of the tetramer structure 
(highlighted in red in Figure 3.6).  Based upon these results, we measured activity of 
ALDOA-related proteins following cleavage of the GST tag.   
 We used native gel electrophoresis to detect tetramer formation of all recombinant 
ALDOA-related proteins following cleavage of the GST tag.  While we loaded equal amounts 
of protein as calculated by extinction coefficients, the amount detected by Sypro stain 
appears to show greater amounts of ALDOA protein (Figure 3.7A).  Out attempt to use 
native gel electrophoresis standards (NativeMark, Invitrogen, Carlsbad, CA) to identify 
tetramers by molecular weight was unsuccessful.  A very large molecular weight protein 
species is present only in the ALDOA lane.  Therefore, only ALDOA formed what appears to 
be a tetramer, while ALDO_V2, ALDOART1, and ALDOART2 formed dimers and monomers 
(Figure 3.7A).  This lack of tetramer formation corresponded with a dramatic reduction in 
FBP aldolase activity for ALDOA_V2, ALDOART1, and ALDOART2 (Figure 3.7B).   
 
Discussion 
Glycolysis is essential for mammalian sperm motility and male fertility [23].   The 
glycolytic pathway is modified during mammalian spermatogenesis through the expression 
of novel spermatogenic-cell specific isozymes [12, 24, 25].  Mammalian sperm express 
multiple isozymes of aldolase A, the glycolytic enzyme which cleaves fructose-1,6-
bisphosphate.  In mouse sperm at least three ALDOA-related proteins are present, 
ALDOA_V2, ALDOART1, and ALDOART2 [12].  While Aldoart1 and Aldoart2 are only 
present in the mouse genome, the alternatively spliced exon present in Aldoa_v2 is 
conserved across species, and ALDOA_V2 protein is detected in human and rat sperm [12].  
Both ALDOA_V2 and ALDOART1 possess N-terminal extensions which may facilitate tight 
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binding to the fibrous sheath, a highly insoluble structure where multiple glycolytic enzymes 
are localized [26].     
We detected high levels of aldolase FBP activity in the insoluble fraction from mouse 
sperm lysates.  The Km value is close to previously published report for mouse sperm 
aldolase A activity [27].  The kinetic values of soluble aldolase FBP activity from mouse 
sperm were comparable to levels from bovine sperm [13]. Previous measurements of bovine 
sperm aldolase excluded activity from insoluble fractions (which may contain novel 
isozymes) and only measured 10% of the total activity in sperm [13].  Unique solubility 
properties of bovine sperm aldolase in various detergents and buffers suggest that there are 
tight stable interactions with other proteins and subcellular structures [13].  The high level of 
activity found in the insoluble fraction correlates with a greater amount of the larger ALDOA-
related proteins in this fraction.  Since we know the fibrous sheath is highly insoluble and 
does not solubilize in Triton X-100-containing buffer, the high levels of aldolase FBP activity 
may be tightly bound to the fibrous sheath where many other glycolytic enzymes are present 
[26].  In fact, proteomic data has previously identified both ALDOA_V2 and ALDOART1 
tightly bound to the fibrous sheath [12].  Components of the fibrous sheath may act as a 
scaffold [28] and may be required for tetramer formation and/or sperm aldolase A activity.   
In order to measure activity of the individual ALDOA-like proteins expressed in 
sperm, we expressed these protein using an E. coli system.  Modeling data suggested that 
ALDOART1 and ALDOART2 might have unique kinetic properties due to modifications near 
the active site.  However, sperm ALDOA-related proteins do not appear to form tetramers 
when expressed in E. coli, and this lack of tetramer formation may contribute to reduced 
FBP activity.  Previous data using recombinant ALDOA demonstrated tetramer formation 
even at very low concentrations (0.2ug/ml) and reported that only very high temperatures 
disrupt tetramer formation [6, 29].  However, aldolase A monomers and dimers are still 
active, suggesting that tetramer formation plays a role in protein stability rather than activity 
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[6].  It is possible that the N-terminal extensions present in ALDOA_V2 and ALDOART1 may 
interfere with tetramer formation.  However, ALDOART2, which does not contain an N-
terminal extension, also does not form tetramers when expressed in E. coli.   
Another possibility is that the sperm ALDOA-related proteins are not properly folded, 
which is required for tetramer formation and activity.  The sperm ALDOA-related proteins 
were soluble using an E. coli expression system. We assessed quaternary structure 
formation through native gel electrophoresis, but we did not confirm accurate secondary and 
tertiary structure formation to confirm proper folding.  Circular dichroism may prove useful for 
verifying proper folding of ALDOA-related enzymes expression in E. coli. 
The sperm ALDOA-related proteins may require post-translational modifications for 
proper folding and tetramer formation, which cannot be completed in an E. coli expression 
system.  In fact, many proteins expressed in sperm are known to form complex disulfide 
bonds not found in any other cell type.  One example is the spermatogenic cell-specific 
glycolytic enzyme, hexokinase (HK1S).  This protein contains a novel 5’ exon which 
encodes an N-terminal domain, the SSR domain.  A cysteine residue located in the SSR 
domain may be responsible for disulfide bond-dependent dimer formation of HK1 [30].  In 
the case of aldolase, ALDOART1 has two unique cysteine residues not found in ALDOA 
(C58 and C253) [12].  Whether disulfide bond formation and other post-translational 
modifications are required for proper folding, tetramer formation, and subsequent activity of 
the sperm ALDOA-related isozymes has not been addressed. 
Expression of sperm ALDOA-related proteins in mammalian cell systems may 
promote proper folding and tetramer formation.  Once tetramers are formed, both FBP and 
F1P activity can be measured to determine the role of sperm aldolase in glycolysis and 
fructolysis.  There is some evidence of fructolytic activity in mouse and human sperm [31-
33], and fructose is found at very high levels in human seminal plasma [34].  Previously, 
endogenous aldolase activity was measured using enzyme purified from tissue.  It would be 
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difficult to separate the four aldolase isozymes in mouse sperm since they are highly 
insoluble.  The sperm ALDOA-related isozymes may be soluble when they are first 
expressed during spermatogenesis in the testis [12].  With that in mind, one possibility is to 
measure activity using testicular lysates combined with gel filtration chromatography to 
distinguish between activity from larger sperm ALDOA-like proteins (ALDOA_V2 and 
ALDOART1) and activity from ALDOART2. 
Sperm ALDOA-related proteins may not exhibit unique catalytic activity and instead 
may play a primary role in facilitating proper localization of aldolase activity to the site of 
glycolytic ATP production in sperm.  Tight binding to the fibrous sheath may be 
accomplished through the presence of N-terminal extension.  Only ALDOA_V2 is conserved 
across species, again supporting a functional role for the N-terminal extension.  In fact, we 
see a distinct trend when we look at multiple glycolytic enzymes localized to the fibrous 
sheath.  GAPDHS, ALDOA_V2, ALDOART1, and a newly identified splice variant of lactate 
dehydrogenase, LDHA_V2, are all tightly bound to the fibrous sheath and contain N-terminal 
extensions when compared to the somatic protein ([12, 26] and unpublished data).  While 
there is no obvious sequence similarity between these N-terminal extensions, the enzymes 
in the glycolytic pathway are being modified through the addition of N-terminal extensions 
which may facilitate tight binding to the fibrous sheath, the site of glycolytic ATP production.   
 We detected high levels of aldolase FBP activity in insoluble fractions of mouse 
sperm lysate.  Although we were unable to determine the kinetic properties of individual 
aldolase isozymes, difficulties experienced when expressing these proteins in an E. coli 
system may highlight distinctive attributes of sperm ALDOA-related proteins.  Defining the 
kinetic properties of aldolase A isozymes will help to understand the regulation of sperm 
metabolism in the context of proper male fertility.   
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Figure 3.1 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.  Enzymatic assay for FBP aldolase activity and definition of kinetic 
parameters.  (A) Diagram depicting the enzymatic reaction used to measure FBP aldolase 
activity.  The substrate, fructose-1,6-bisphosphate (FBP) is cleaved by Aldolase and 
produces glyceraldehyde-3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP).  
G3P is converted to DHAP by triose phosphate isomerase (TPI).  DHAP is then metabolized 
by α-glycerophosphate dehydrogenase (α-GDH) to produce 2α-glycerophosphate.  This final 
step oxidizes β-NADH to β-NAD, which can be read by the decrease in absorbance at 
340nm, therefore measuring FBP aldolase activity.  (B)  Graph depicting the calculation of 
kinetic parameters Km and Vmax.  By measuring the velocity of an enzymatic reaction (v0) 
over varying concentrations of substrate [S], one can plot an exponential curve using the 
Michaelis-Menten equation, Y=VmaxX/(Km+X), where X is the substrate concentration [S] and 
Y is the velocity (v0).  This equation is used to calculate the Vmax, or the maximum velocity of 
the reaction, and the Km, the concentration of substrate at which the Km is one-half.   
B. 
A. 
FBP
Aldolase
DHAPG3P  + 2α-glycerophosphate
α-GDH
TPI
β-NADH β-NAD
  
 
90
Figure 3.2 
 
 
 
Figure 3.2.  Kinetic analysis of endogenous mouse sperm FBP aldolase.  (A) Protein 
from sperm isolated in 1% Triton-X-100-containing buffer and ß-mercaptoethanol were 
separated by centrifugation.  Protein loads were adjusted to 5 x 105 cell equivalents  for the 
lysate and pellet samples and 7.5 x 105 cell equivalents for the supernatant sample.  Total 
protein lysate, supernatant (S/N) and pellet were resolved by 10% SDS-PAGE, transferred 
to PVDF and stained with coomassie blue to demonstrate equal loading.  The same 
samples were processed for western blotting using an anti-aldolase antibody.  Larger 
amounts of the 50kDa aldolase species are found in the pellet fraction.  (B) Michaelis-
Menten curves showing FBP aldolase activity of the three sperm samples.  Specific activity 
is measure as units per 108 sperm.  For values of kinetic parameters see Table 3.2.          
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Figure 3.3 
 
 
 
 
 
ALDOA 29 GILAADESTGSIAKRLQSIGTENTEENRRFYRQLLL 67  
ALDOA_V2 83 ************************************ 121  
ALDOART1 82 ********I**MGN****************F***** 120 
ALDOART2 29 ************************************ 67  
 
ALDOB 29 ********V*TMGN***R*KV********QF*E**F 67  
ALDOC 29 ********V**M****SQ**V********L***V*F 67  
 
 
 
 
 
ALDOA 225 EGTLLKPNMVTPGHACTQKFSNEEIAMATVTALRRTVPPAVTGVTFLSGGQSE 276 
ALDOA_V2 279 ***************************************************** 330 
ALDOART1 278 *****************************************P*********** 329 
ALDOART2 225 ***********A******V**S*******************P*********** 276 
 
ALDOB 225 ***********A*****K*YTP*QV********H****A**P*IC*****M** 276 
ALDOC 225 ***********P****PI*Y*P*******************P*********** 276 
 
 
 
Figure 3.3.  ALDOB-like residues found in ALDOART1 and ALDOART2 sit in between 
active site residues.  Amino acid alignment of all ALDO-related proteins highlighting four of 
the eight known active site residues [14].  Asterisks (*) denotes identical amino acid 
residues.  Amino acids highlighted in pink are active site residues, conserved in all ALDO-
related proteins.  Residues highlighted in green are unique to ALDOART1 and ALDOART2 
and more similar to ALDOB.  Three isozyme-specific residues in ALDOB are found in 
ALDOART1 (denoted by black arrows).   
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Figure 3.4 
 
 
 
 
 
Figure 3.4.  Unique amino acid residues in ALDOART1 and ALDOART2 are found on 
the outside of the protein or near the substrate binding pocket.  Three-dimensional 
protein structure models highlighting the differences between ALDOA isozymes expressed 
in sperm.  Using the ALDOA monomer structure, we highlighted active site residues (blue, 
[14]) and unique residues in ALDOART1 and ALDOART2 (red).  We also highlighted 
residues in ALDOART1 and ALDOART2 which are identical to ALDOB (light blue).   
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Figure 3.5 
 
 
 
 
 
 
 
Figure 3.5.  GST-ALDOA_V2 has reduced FBP aldolase activity when compared to 
GST-ALDOA.  Michaelis-Menten curves showing FBP aldolase activity of recombinant GST-
ALDOA and GST-ALDOA_V2.  Specific activity is shown as units per mg of recombinant 
protein.  For values of kinetic parameters see Table 3.3.      
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Figure 3.6 
 
 
 
 
 
Figure 3.6.  The N-terminus of ALDOA sits in the center of the tetramer structure.  
Three-dimensional protein structure of aldolase A tetramer.  Image modified from [15].  Each 
subunit of the tetramer is labeled A-D.  Highlighted in red are the first seven residues 
(excluding methionine not included in the structure) of the N-terminus of ALDOA.   
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Figure 3.7 
 
 
 
 
 
 
Figure 3.7.  Spermatogenic-cell specific ALDOA-related recombinant proteins do not 
form tetramers and have reduced activity when expressed in E. coli.  (A) Native gel 
electrophoresis of ALDOA-related recombinant proteins followed by Sypro Ruby staining.  
Equal protein load was measured by absorbance, although Sypro stain appears to show 
varying protein load.  Large molecular weight protein species may represent tetramers, only 
present in ALDOA lane.  (B) Michaelis-Menten curve showing FBP aldolase activity of 
recombinant spermatogenic-cell specific ALDOA-related proteins.  Specific activity is 
measured as units per mg of recombinant protein.  ALDOA_V2, ALDOART1, and 
ALDOART2 have dramatically reduced activity when compared to ALDOA.  Number in 
parenthesis next to protein name in key denotes the number of protein preparations used.      
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Table 3.1.  Kinetic properties of purified rabbit aldolase isozymes [8] 
Aldolase A B C 
Tissue source Muscle (Brain) Liver Brain 
Km FBP (µM) 4 1 2 
Vmax FBP (units/mg) 16.5 1.0 6.5 
Km F1P (µM) 5000 300 4000 
Vmax F1P (units/mg) 0.33 1.0 0.65 
FBP/F1P ratio    
(Vmax FBP/Vmax F1P) 50 1 10 
 
Vmax is the enzyme’s maximum rate, while Km is the concentration of substrate where the 
Vmax is ½.  
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Table 3.2.  Kinetic properties of endogenous mouse sperm aldolase isozymes 
Sperm sample Lysate S/N Pellet Purified [13] 
Km FBP (µM) 47 28 37 7 
Vmax FBP 
(units/108 sperm) 0.81 0.16 0.69 0.104 
 
Vmax is the enzyme’s maximum rate, while Km is the concentration of substrate where the 
Vmax is ½.  
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Table 3.3.  Kinetic properties of recombinant sperm aldolase isozymes 
GST protein ALDOA ALDOA_V2 
Km FBP (µM) 94 430 
Vmax FBP (units/mg) 6.2 4.2 
 
Vmax is the enzyme’s maximum rate, while Km is the concentration of substrate where the 
Vmax is ½.   
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CHAPTER 4 
FREQUENT RETROTRANSPOSITION OF ORTHOLOGOUS GENES IN THE 
GLYCOLYTIC PATHWAY 
 
Abstract 
In the central metabolic pathway of glycolysis, each reaction is catalyzed by multiple 
isozymes encoded by a multigene family.  Gene targeting studies of multiple spermatogenic 
cell-specific glycolytic isozymes indicate that glycolysis is essential for sperm function and 
male fertility in mouse.  In addition to Pgk2, a well-characterized retrogene expressed in all 
eutherian mammals, at least two other spermatogenic cell-specific glycolytic enzymes in the 
mouse (Aldoart1, and Aldoart2) are encoded by retrogenes.  The restricted expression of 
these retrogenes during spermatogenesis suggests that retrotransposition may play a 
significant role in the evolution of sperm glycolytic enzymes.  We conducted a 
comprehensive genomic analysis of glycolytic enzymes in the human and mouse genomes 
and identified several intronless copies for all enzymes in the pathway, except Pfk.  Within 
each gene family, a single orthologous gene was typically retrotransposed frequently and 
independently in both species.  Sequence alignment of each retroposed sequence against 
the parent mRNA transcript identified those sequences with alternatively spliced exons 
and/or open reading frames.  Retroposed sequences that maintained open reading frames 
and <99% sequence identity in the coding region were tested for expression in the testis and 
in isolated germ cells.  These studies provided evidence for the expression of an alternative 
Gpi1 transcript in mouse spermatogenic cells.  A striking number of related sequences were 
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immediately adjacent to autonomous repetitive elements (LINEs and LTRs) known to be 
actively retrotransposed in the germline.  Our analysis detected frequent, recent, and 
lineage-specific retrotransposition of orthologous glycolytic enzymes in the human and 
mouse genomes.  Retrotransposition events are LINE/LTR-dependent and genomic 
integration is random.  Many retroposed sequences have maintained open reading frames, 
suggesting a functional role for these genes.   
 
Introduction 
Although glycolysis is highly conserved, this central metabolic pathway is modified 
extensively during spermatogenesis. There are several glycolytic isozymes with restricted 
expression in the male germline including glyceraldehyde 3-phosphate dehydrogenase-S 
(GAPDHS) [1, 2], phosphoglycerate kinase 2 (PGK2) [3], lactate dehydrogenase-C (LDHC) 
[4, 5] and two aldolase A-related isozymes, ALDOART1/ALDOART2 in mouse [6].  Other 
unique sperm isozymes in this pathway are generated by alternative splicing, including 
hexokinase-1 (HK1S); [7-9], ALDOA_V2 [6], and a pyruvate kinase muscle form isozyme 
(PK-S) [10, 11].  There is also evidence that other glycolytic enzymes have unique functional 
or structural properties in mammalian sperm, including glucose phosphate isomerase (GPI1) 
[12, 13], triose phosphate isomerase (TPI) [14], enolase (ENO) [15-17], and 
phosphofructokinase (PFK) [18].  Targeted gene disruption of genes encoding three 
spermatogenic cell-specific glycolytic enzymes (Gapdhs, Pgk2, and Ldhc) demonstrates an 
essential role of these enzymes in sperm motility and male fertility [19-21].   
The glycolytic pathway is comprised of ten enzymes, each encoded by a family of 
genes [10].  Seven of these gene families have two to five intron-containing genes, while the 
Gpi1, Tpi1, and Pgk families each have only one.  Within a family, each gene encodes a 
different isoform with a unique expression pattern [10].  Many of these gene families arose 
by multiple rounds of gene duplication in the last 100 million years [10].  However, the Pgk 
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gene family expanded through retrotransposition [3, 22].  In addition, we recently identified 
two aldolase A (Aldoa) retrogenes in the mouse genome [6].   
Spermatogenic cell-specific glycolytic isozymes are expressed from genes generated 
by either gene duplication (Gapdhs, Ldhc) or retrotransposition (Pgk2, Aldoart1, Aldoart2) 
[3, 6, 22-24].  Pgk2 represent an ancient retrotransposition event shared by all eutherian 
mammals, while Aldoart1 and Aldoart2 are only found in the rodent lineage and are much 
more recent [6, 25].  In addition, frequent retrotransposition of the Gapdh and Aldoa genes 
has been reported in both human and mouse, based on an abundance of pseudogenes [26-
29].   
Theoretically, retrotransposition can occur in any cell type, but the retrotransposition 
event is only transmitted to future generations when it takes place in the germline [30-33].  
Retrotransposition is facilitated by repetitive elements (including LINE and LTR elements) 
resulting in the creation of pseudogenes or retrogenes [34].  In the human lineage most LTR 
elements have been extinct for over 40 million years.  However, LINE elements are still 
active and are therefore thought to be responsible for most retroposed mRNA sequences 
[34].  The proteins encoded by LINE elements, ORF1 and ORF2, are expressed in testicular 
germ cells undergoing meiosis (spermatocytes), a period when retrotransposition is thought 
to occur [30, 33, 35].  In fact, retrotransposition is responsible for the creation of many 
retrogenes translated only during the haploid phase of spermatogenesis, including but not 
limited to Pgk2, G6pd, and Pabp2 [3, 22, 36, 37].  At least 10% of retroposed sequences 
with open reading frames are transcribed during spermatogenesis [35, 38-40].  Positive 
selection of sperm proteins, combined with frequent retrotransposition to create genes 
encoding sperm-specific proteins, results in the faster evolution of genes involved in sperm 
function [41]. 
Sperm motility is dependent upon the production of high levels of ATP in the 
flagellum [42-44].  It has been shown that glycolysis, rather than mitochondrial oxidative 
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phosphorylation, is required for sperm motility and male fertility in mice [19, 45].  Fertilization 
is an evolutionarily fine-tuned process that requires the successful completion of a cascade 
of events, including changes in sperm motility required for reaching the site of fertilization in 
the female reproductive tract and penetrating the zona pellucida surrounding the oocyte.  A 
recent study of 1085 patients with male factor infertility found that approximately 81% exhibit 
defects in sperm motility, with 19% having no other defects in sperm count or morphology   
[46].  The expression of genes that promote high sperm motility can increase reproductive 
fitness, while disruptive mutations in genes essential for sperm motility can hinder proper 
fertilization, leading to infertility.  In humans, genes involved in spermatogenesis and sperm 
motility demonstrate the strongest evidence for positive selection, and proteins involved in 
reproduction are among the most rapidly evolving genes across multiple species [47, 48].  
Based on the existence of Pgk2 and Aldoa-related retrogenes and their restricted 
expression during spermatogenesis, we hypothesized that there may be additional 
retrogenes that encode novel sperm glycolytic enzymes.  Therefore, we conducted a 
comprehensive genomic analysis to identify all human and mouse retroposed sequences 
that are derived from genes encoding glycolytic enzymes.  We analyzed the gene structure 
of these sequences and determined which copies maintain open reading frames, are 
transcribed, and may encode sperm-specific isoforms of glycolytic enzymes.  Unique 
features of sperm glycolytic isozymes may be important for localization of this pathway in the 
prinicipal piece of the sperm flagellum or for altered regulation or kinetic properties that may 
be required to sustain sperm metabolism and motility in this highly polarized cell. Taken 
together, identification of all sperm-specific glycolytic enzymes will improve our 
understanding of sperm metabolism at a molecular level and may provide insights regarding 
the rapid evolution of genes required for reproduction.   
  107
Methods 
Identification of gene families 
The Ensembl (http://www.ensembl.org) Interpro Domain was used to identify the 
intron-containing genes for each glycolytic enzyme [49].  We used Ensembl release 48 (Dec 
2007) to identify all genes, the mRNA sequence, and their chromosome location.  Accession 
numbers used for BLAST are as follows: 
 
Human:  HK1 [ENSG00000156515] HK2 [ENSG00000159399] HK3 [ENSG00000160883], 
GCK [ENSG00000106633], HKDC1 [ENSG00000156510], GPI1 [ENSG00000105220], 
PFKL [ENSG00000141959], PFKM [ENSG00000152556], PFKP [ENSG00000067057], 
ALDOA [ENSG00000149925], ALDOB [ENSG00000136872], ALDOC 
[ENSG00000109107], TPI1 [ENSG00000111669], GAPDH [ENSG00000111640], GAPDHS 
[ENSG00000105679], PGK1 [ENSG00000102144], PGAM1 [ENSG00000171314], PGAM2 
[ENSG00000164708], PGAM5 [ENSG00000176894], ENO1 [ENSG00000074800], ENO2 
[ENSG00000111674], ENO3 [ENSG00000108515], DKFZp781N1041 
[ENSG00000188316], PKLR [ENSG00000143627], PKM2 [ENSG00000067225]. 
 
Mouse:  Hk1 [ENSMUSG00000037012], Hk2 [ENSMUSG00000000628], Hk3 
[ENSMUSG00000025877], Gck [ENSMUSG00000041798], Hkdc1 
[ENSMUSG00000020080], Gpi1 [ENSMUSG00000036427], Pfkl 
[ENSMUSG00000020277], Pfkm [ENSMUSG00000033065], Pfkp 
[ENSMUSG00000021196], Aldoa [ENSMUSG00000030695], Aldob 
[ENSMUSG00000028307], Aldoc [ENSMUSG00000017390], Tpi1 
[ENSMUSG00000023456], Gapdh [ENSMUSG00000057666], Gapdhs 
[ENSMUSG00000061099], Pgam1 [ENSMUSG00000011752], Pgam2 
[ENSMUSG00000020475], Pgam5 [ENSMUSG00000029500], Eno1 
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[ENSMUSG00000063524], Eno2 [ENSMUSG00000004267], Eno3 
[ENSMUSG00000060600], 6430537H07Rik [ENSMUSG00000048029], Pklr 
[ENSMUSG00000041237], Pkm2 [ENSMUSG00000032294]. 
 
BLAST search for retroposed sequences 
We blasted the mRNA sequence for each gene encoding a glycolytic enzyme using 
Ensembl BlastView in order to search both the mouse and human genome for retroposed 
sequences.  We grouped BLAST hits based upon chromosome location and excluded hits 
that were less than 50 base pairs.  By comparing BLAST results between gene family 
members, we identified the parent gene for each retroposed sequence.  For each 
retroposed sequence, we identified the parent gene by choosing matches with the longest 
hit and the highest percentage match.  Using the BLAST results, we calculated the weighted 
average of the nucleotide identity of all retroposed sequences matching glycolytic enzymes.  
Ensembl was used to retrieve the FASTA sequence for each retroposed sequence on the 
appropriate strand.   
 
Sequence alignment  
Sequencher 4.8 (Gene Codes Corporation, Ann Arbor, MI) was used to align all 
retroposed sequences to their parent gene.  We used large gap parameters and 60% 
identity threshold to align all sequences to the reference sequence (the parent gene).  At the 
nucleotide level we looked for insertions and/or deletions, base pair substitutions, and exon 
structure.  We then calculated the percent identity of the coding sequence and looked for an 
open reading frame.  Amino acid sequence alignments were performed using ClustalW 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) [50]. 
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Tissue and cell isolations 
Outbred CD-1 mice were obtained from Charles River (Raleigh, NC).  All procedures 
involving animals were approved by the University of North Carolina at Chapel Hill Animal 
Care and Use Committee and conducted in accordance with the Guide for the care and Use 
of Laboratory Animals (Institute for Laboratory Animal Research, National Academy of 
Sciences).   
All tissues were quick frozen in liquid nitrogen and kept at -80°C until use.  Testicular 
germ cells were isolated using an established protocol [51]. Briefly, we purified pachytene 
spermatocytes, round spermatids, and condensing spermatids by unit gravity sedimentation 
from adult mixed germ cell suspensions [51].  Pachytene spermatocytes and round 
spermatids have purities of > 90%, while fractions containing condensing spermatids have 
30-40% nucleated cells and cytoplasts.  Testes from 17-day-old mice were used to isolated 
Sertoli cells, as previously described [52]. 
Mouse sperm was collected as previously described [6].  Briefly, clipped cauda 
epididymis were incubated for 15 minutes at 37 °C in p hosphate-buffered saline with 
protease inhibitors (PBS + PI) containing 140 mM NaCl, 10 mM phosphate buffer (pH 7.4) 
and Complete protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany).   
Human sperm samples were obtained from healthy donors provided by the Andrology 
Laboratory, Department of Obstetrics and Gynecology, University of North Carolina School 
of Medicine. These samples were washed twice with PBS to remove seminal plasma and 
cryopreserved. 
 
RT-PCR expression analysis of newly identified retroposed sequences in mouse and human 
tissues and cells 
Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA) from either cells or 
tissues pooled from at least three mice.  Adult tissues included brain, heart, ovary and testis, 
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and cells included isolated testicular cells.  The Qiagen RNeasy Midi Kit (Qiagen 
Incorporation, Valencia, CA) was used to remove genomic DNA contamination from RNA 
preparations.  RNA was quantified using the NanoDrop spectrophotometer (NanoDrop 
Technologies, Wilmington, DE).  Human RNA was purchased from Clontech (Mountainview, 
CA) and was prepared from pooled tissues from 39 individuals.  Genomic DNA isolated from 
CD1 mice and two human subjects were used as positive controls for detected of PCR 
amplified retrogenes.  Reverse transcription followed by gene-specific polymerase chain 
reaction (Superscript RT II, Invitrogen, Carlsbad, CA; Taq DNA polymerase, New England 
BioLabs, Ipswich, MA) was used to amplify transcripts from total RNA samples.  
Two primer pairs were designed to detect expression of Gpi1-related transcripts in 
mouse RNA samples.  The first primer pair distinguishes between transcripts that contain 
alternatively spliced exons 5 and 6 (Figure 4.4A):  Gpi1F in exon 4 
(5’GAGGTGAACAGGGTTCTGGA3’), Gpi1R in exon 11 (5’GCTCGAAGTGGTCAAAACC3’).  
The expected product sizes are as follows:  Gpi1, 520 base pairs; Gpi1_v2/Gpi1-rs1, 288 
base pairs.  The second primer pair is specific for Gpi1-rs1F in exon 4 
(5’ATCAAGGTGGTCGGG3’), Gpi1-rs1 R in exon 10 (5’CAATGGAAGGTCCAG3’).  We also 
included a negative control with no reverse transcriptase to control for genomic DNA 
contamination.  All PCR products were resolved by 2% agarose gel electrophoresis and 
visualized by ethidium bromide staining using UV detection.   
To detect expression of human retroposed sequences primers were designed to 
amplify and incorporate α-[32P]-dCTP into the same size product from the parent gene and 
the retroposed sequences of interest:  Tpi1/Tpi1-rs1, Pgam1/Pgam1-rs1, and Eno1/Eno1-
rs1.  The forward primer sequence for Tpi1/Tpi1-rs1 was 5′CCGACACCGAGGTGGTTT3′ 
and the reverse primer sequence was 5′GTTCTGCGCAGCCACAGCAA3′. The forward 
primer sequence for Pgam1/Pgam1-rs1 was 5′GCAGACCTCACAGAAGATCAG3′ and the 
reverse primer sequence was 5′ACAGATGTGGTCAGTGTGACAT3′. The forward primer 
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sequence for Eno1/Eno1-rs1 was 5′TTGGGAAAGCTGGCTACACT3′ and the reverse primer 
sequence was 5′ CCAGTCATCCTGGTCAAAGG 3′.  Arrows in Figure 4.3A denote the 
location of these primers in each gene. 
As a positive control to confirm proper spermatogenesis in human testis samples, we 
detected expression of protamine 1 (Prm1) in RNA samples.  We also included a negative 
control with no reverse transcriptase to control for genomic DNA contamination.  The 
forward primer sequence for Prm1 was 5’TCACAGGTTGGCTGGCTC3’and the reverse 
primer sequence was 5’CATTGTTCCTTAGCAGGCTCC3’ [53].  Following PCR 
amplification with both primer sets, the products were resolved by Single Strand 
Conformation Polymorphism (SSCP) electrophoresis using MDE gel solution (Cambrex, 
East Rutherford, NJ) at 0.5W for 19 hours. Genomic DNA was used as a control template in 
parallel PCR reactions to confirm the expected electrophoretic pattern of the retroposed 
sequences. Gels were exposed to Super RX X-ray film (Fujifilm, Tokyo, Japan) using 
intensifying screens to detect incorporation of α-[32P]-dCTP into amplified products. 
 
Western analysis of GPI1-related proteins  
Lysis buffer (2% SDS, 100 mM DTT, 125 mM Tris pH 6.8, 18% glycerol) was used to 
extract proteins from tissues or isolated cells.  Samples were centrifuged at 16,000×g for 
10 min at 4 °C following homogenization.  Concentrat ion of protein samples was determined 
using the micro-BCA assay (Pierce Biotechnology, Rockford, IL).  SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) on 7.5% polyacrylamide gels were used to separate samples 
of equal protein amounts, followed by electrophoretically transfer to Immobilon-P PVDF 
(polyvinylidene fluoride) membranes (Millipore Corp, Bedford, MA).  Coomassie blue R250 
staining (0.1% Coomassie blue R250 in 45% methanol, 10% acetic acid) of staining 
detected equal loading following protein transfer.  Following staining, membranes were 
destained, rinsed with TBS-T (140 mM NaCl, 3 mM KCl, 0.05% Tween-20, 25 mM Tris–HCl, 
  112
pH 7.4) and incubated in blocking buffer (5% nonfat dry milk in TBS-T) overnight at 4 °C. 
Antibody incubations were performed at room temperature in blocking buffer.  Membranes 
were then incubated with a 1:500 dilution of a polyclonal antibody raised against a 
recombinant human glucose phosphate isomerase protein fragment (Strategic Diagnostic 
Incorporation, Newark, DE) for 2 hours. Membranes were incubated for 45 min at room 
temperature with secondary antibody (affinity-purified horseradish peroxidase-conjugated 
rabbit anti-goat IgG, KPL, Gaithersburg, MD) diluted 1:10,000. Following antibody 
incubations membranes were rinsed for 5 minutes with TBS-T.  Immunoreactive proteins 
were detected by enhanced chemiluminescence using the SuperSignal West Pico substrate 
(Pierce Biotechnology, Rockford, IL) and HyBlot CL autoradiography film (Denville Scientific, 
Metuchen, NJ). 
 
Repetitive Element Analysis  
Galaxy (http://galaxy.psu.edu) was used to obtain both 1kb and 10kb FASTA format 
sequence flanking retroposed sequences and genes encoding glycolytic enzymes [54].  We 
analyzed FASTA format sequence for all retroposed sequences, 1kb flanking retroposed 
sequences and 1kb flanking genes encoding glycolytic enzymes for the presence of 
repetitive elements using Repeatmasker (http://www.repeatmasker.org).  We calculated the 
percent frequency of repetitive elements (LINE, LTR, and SINE) in each base pair within 1 
kb upstream or downstream of retroposed sequences or genes encoding glycolytic 
enzymes. Chi-square values were calculated using a contingency table comparing mouse 
and human sequences versus glycolytic enzymes and retroposed sequences for each 
repetitive element.   (G+C) content was calculated using the eMBOSS geecee program 
(http://cat.toulouse.inra.fr/apps/emboss/emboss.cgi/geecee) [55].  
BLAST search for extensions 
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Repeatmasker (http://www.repeatmasker.org) was used to generate sequence with 
the repetitive elements masked (represented by “n”) [56].  We repeatmasked the 1kb 
sequence flanking all retroposed sequences and used Ensembl BLAST to compare this 
sequence to the mouse or human genome.  We looked for matches with genomic locations 
close to either the parent gene or other retroposed sequences, indicative of a sequence 
extension at the end of the gene.   
 
Results 
Frequent retrotransposition of orthologous genes encoding glycolytic enzymes occurred 
independently in the mouse and human genomes 
Ten gene families that compose the glycolytic pathway consist of 25 intron-
containing genes in the human and mouse genomes (Table 4.1).  We identified retroposed 
sequences in the human and mouse genomes for each family of glycolytic enzymes, except 
phosphofructokinase (Pfk).  Major conclusions from this analysis are:   
 Retrotransposition of genes encoding glycolytic enzymes is frequent.  We identified 
94 matching retroposed sequences in the human genome and 291 in the mouse 
genome. Our analysis confirms that the mouse genome contains significantly more 
retroposed sequences than the human genome [57].   
 As a rule, only one gene within each family is retroposed.   
 The same orthologous gene is retroposed in the human and mouse genomes 
(bolded font in Table 4.1).  This is always true in cases where there is more than one 
matching retroposed sequence.  The two exceptions to this rule, hexokinase (Hk) 
and phosphoglycerate mutase (Pgam) have a single retroposed sequence in one or 
both species.  In the human genome HK2 is retroposed, while Hk1 is retroposed in 
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the mouse genome.  There is a single Pgam5 retroposed sequence in mouse in 
addition to multiple retroposed sequences for Pgam1 in both species.  
 Human retroposed sequences are more divergent from their parent genes when 
compared to mouse retroposed sequences (Figure 4.1).   
 Retrotransposition events occurred independently in each lineage following the 
divergence of primates and rodents.  Phylogenetic analysis was inconclusive in 
determining the strict order of retrotransposition events due to the high levels of 
sequence identity.  However, analysis of flanking sequence confirmed a lack of 
conservation of synteny between sequences in the human and mouse genome.  
Taken together, our analysis found frequent, independent retrotransposition of 
orthologous genes encoding glycolytic enzymes.     
 The location of retroposed sequences in the human (Supplemental Table 4.1) and 
mouse (Supplemental Table 4.2) genomes appears to be random.  There is no 
region or chromosome with an overrepresentation of retroposed sequences.  There 
is also evidence for gene duplication of retrotransposed sequences (see legend for 
Supplemental Tables 4.1 and 4.2).   
 
3-6% of retroposed sequences have open reading frames 
6.3% of human retroposed sequences derived from genes encoding glycolytic 
enzymes and 3.4% of mouse sequences contain open reading frames (ORFs) (Figure 4.2).  
This value includes the previously identified Pgk2, Aldoart1, and Aldoart2 retrogenes.  In this 
study we identified five new retroposed sequences with ORFs in the human genome and 
seven new retroposed sequences with ORFs in the mouse genome (gene structure with red 
and yellow boxes representing segments of the ORF that match exons in the parent gene, 
Figure 4.2).  Numbers next to each gene structure indicate the percent identity of each 
retroposed sequence compared to the parent gene.  Most retroposed sequences with ORFs 
  115
are more similar to the parent gene (>99%) and represent recent retrotransposition events 
(eg., PGAM1-rs4).  However, there are examples of retroposed sequences that are much 
older (eg., ENO1-rs1).    
Three of the five human retroposed sequences with ORFs were derived from 
PGAM1 (Figure 4.2).  Both PGAM1-rs1 and PGAM1-rs4 have greater than 99% sequence 
identity at the nucleotide level compared to PGAM1, indicative of recent retrotransposition, 
while PGAM1-rs7 is only 98.3% identical and has 11 unique amino acid residues 
(Supplemental Figure 4.1).  Three of the mouse retroposed sequences have less than 99% 
sequence identity at the nucleotide level, including Pgk1-rs1 and Pgk1-rs2 (Figure 4.2).  
Figure 3 shows the percent identity of the coding sequence in retroposed sequences, which 
is 100% identical for both Pgk1-rs1 and Pgk1-rs2.  Both Pgk1-related sequences have less 
than 99% sequence identity in the 3’UTR due to a 5 base pair insertion.  We did not detect 
transcription of either Pgk1-related sequence in mouse testis cDNA (data not shown).  
These results indicate that several retroposed sequences matching glycolytic enzymes in 
both the human and mouse genomes have open reading frames, supporting possible 
expression of these sequences.       
 
Detection of splice variants in the glycolytic enzyme parent genes 
Analysis of retroposed sequences in both the human and mouse genomes support 
the expression of alternative transcripts from the parent genes.   Two retroposed sequences 
in humans (ALDOA-rs1 and TPI1-rs3) suggest alternative splicing of internal exons 
(represented as boxes with diagonal lines in Figure 4.2).  For example, TPI1-rs3 is missing 
the last 2.5 exons, but still contains part of the last exon when compared to TPI1 (box with 
lines, Figure 4.2).  Alternative splicing is also supported by two mouse retroposed 
sequences (Gpi1-rs1 and Eno1-rs5) (boxes with diagonal lines, Figure 4.2).  For example, 
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Eno1-rs5 matches full length Eno1, except for a deletion of the last 1.5 exons (box with 
lines, Figure 4.2).  The remaining 3’UTR is maintained, without the coding sequence.   
 
Detection of N-terminal extensions in the glycolytic enzyme parent genes 
Multiple mouse and human retroposed sequences have upstream start codons, 
supporting the expression of transcripts that encode glycolytic enzymes with N-terminal 
extensions.  Three human sequences (TPI1-rs1, PGK1-rs1 and PGAM1-rs6) and eight 
mouse sequences (Gpi1-rs1, Tpi1-rs5, Eno1-rs5,9, and Pkm2-rs1,2,3,8) contain upstream 
start codons (black exons, Figure 4.2).  In most cases, comparison of the amino acid 
sequence in these N-terminal extensions reveal a unique origin for these extensions that is 
independent from the parent genes (Supplemental Figure 4.2).  Alignment of the amino acid 
sequence does not show a high level of identity.  Five retroposed sequences matching 
Pkm2 in mice contain N-terminal extensions.  Previous data support the expression of a 
larger Pkm2 transcript in bovine and mouse sperm [11, 58].  Proteomic evidence from 
bovine sperm suggests extension of the N-terminus by at least four amino acids [11].  Our 
sequence analysis of Pkm2 pseudogenes with upstream start codons in the mouse genome 
agrees with the previously identified four amino acid extension, but does not clearly 
elucidate the start codon responsible for the larger protein product detected in sperm 
(Supplemental Figure 4.2B).   
 
Novel open reading frames with divergent sequences are not expressed in human testis 
Expression of retroposed sequences with greater than 99% identity at the nucleotide 
level would be difficult to distinguish from parent gene expression.  However, we did analyze 
expression of three human sequences with ORFs and less than 99% nucleotide identity in 
the coding sequence (TPI1-rs1, PGAM1-rs7, ENO1-rs1, and Supplemental Figure 1).  Due 
to high sequence similarity at the nucleotide level, we used Single Strand Conformation 
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Polymorphism (SSCP) gel electrophoresis to examine potential expression of these 
retroposed sequences in human testis (Figure 4.3A).  Here, RT-PCR products are 
denatured into two strands and separated based upon individual nucleotide differences.  
This method allowed us to distinguish between sequences with very high levels of identity.  
We used genomic DNA to identify the migration pattern of the PCR products amplified from 
the retroposed sequences (G1 and G2, Figure 4.3B).  Expression of protamine 1 (PRM1), a 
spermatid-specific transcript, was detected in human cDNA preparations, confirming 
complete spermatogenesis in the pooled testes tissues used for RNA isolation.  With 
primers specific for TPI-rs1, PGAM1-rs7, and ENO1-rs1, RT-PCR did not amplify products 
from human testis RNA that match the retroposed sequence fragments amplified from 
genomic DNA (Figure 4.3B).  Therefore, we did not detect expression of any of the human 
retroposed sequences with ORFs in testis.    
 
Expression of an alternative Gpi1 transcript in mouse spermatogenic cells 
Gpi1-rs1 maintains an open reading frame, despite missing two internal exons 
(Figure 4.4A).  The open reading frame of Gpi1-rs1 suggests the expression of this 
retroposed sequence and/or a Gpi1 splice variant missing exons 5 and 6 (Gpi1_v2, 
Supplemental Figure 4.3).  RT-PCR expression analysis in mouse tissues revealed a testis-
specific transcript of glucose phosphate isomerase, representative of Gpi1_v2 and/or Gpi1-
rs1 (Figure 4.4B).  This transcript was also detected in both pachytene spermatocytes and 
round spermatids isolated from mouse testis, but not in later germ cells (condensing 
spermatids) or Sertoli cells.  The same band was detected in human testis, but due to the 
absence of Gpi1-rs1 in the human genome, must represent the expression of GPI1_V2 
(data not shown).   
To distinguish between Gpi1_v2 and Gpi1-rs1 expression, we designed PCR primers 
to specifically detect expression of Gpi1-rs1 (Figure 4.4A).  Using this approach, we did not 
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detect a Gpi1-rs1-specific product (Figure 4.4B, bottom panel), indicating that PCR products 
initially detected in pachytene spermatocytes (Figure 4.4A, top panel) are most likely derived 
from Gpi1_v2 transcripts. 
 We detected expression of the GPI1 protein in various tissues and germ cells 
isolated from mouse testis (Figure 4.4C).  GPI1 has 553 amino acids, while GPI1_V2 has 
476 amino acids since it is missing sequence encoded by exons 5 and 6 (Supplemental 
Figure 4.3).  GPI1-rs1 is also missing sequence encoding exons 5 and 6 but contains an N-
terminal extension and is, therefore, 502 amino acids (Supplemental Figure 4.3).  The 
predicted molecular weights of GPI1, GPI1_V2, and GPI1-rs1 are, 62,800, 54,500, and 
55,100, respectively.  We detected a protein band that migrates with an apparent molecular 
weight of ~55,000 in all tissues analyzed.  This band is assumed to be GPI1 due to its 
ubiquitous expression pattern.  We also identified a larger immunoreactive band that was 
seen only in isolated spermatogenic cells (Figure 4.4C).  This protein is not present in 
human or mouse sperm and is larger than the predicted molecular weights of GPI1_V2 and 
GPI1-rs1.   We also found that glucose phosphate isomerase is soluble in the supernatant 
fraction following sonication of sperm (s/n, Figure 4.4C).  Since GPI1 is not found in 
insoluble fractions of mouse sperm, it is not tightly bound to the fibrous sheath, the 
cytoskeletal structure in the sperm flagellum that binds multiple glycolytic enzymes with 
unique N-terminal extensions [6].  Although we were unable to distinguish GPI1_V2 in our 
Western analysis, we identified an alternative splice variant of Gpi1 that is transcribed in 
spermatogenic cells of the mouse testis.        
 
Repetitive elements are overrepresented in sequence flanking retroposed sequences 
The Aldoart1 sequence provided evidence for an alternative splice variant 
(Aldoa_v2) of aldolase A that is also expressed during spermatogenesis [6].  In our analyses 
of other retroposed sequences, we examined flanking sequences for evidence of alternative 
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splicing or additional coding sequence particularly at the N-terminus.  Analysis of 1kb 
sequence both upstream and downstream of all human and mouse retroposed sequences 
did not identify additional coding sequences.  Instead, we found a significant (P < 0.01) 
increase in the number of repetitive elements, particularly LINE and LTR elements, in 
regions that flank retroposed sequences compared to comparable regions that flank the 
parent genes (intron-containing genes encoding the glycolytic enzymes) (Supplemental 
Figure 4.4).   
We calculated the percent frequency of both LINE and LTR elements at each base 
pair within 1 kb upstream and downstream of each retroposed sequences, as compared to 
intron-containing parent genes encoding glycolytic enzymes.  We observed an increase in 
LINE and LTR elements along the entire 1kb immediately upstream or downstream of 
retroposed sequences (Figure 4.5A).  Because LINE elements are found preferentially in 
(A+T)-rich regions of the genome [57], we expected a low (G+C) content in the the flanking 
regions (10kb) of retroposed sequences.  Surprisingly, we found that the (G+C) content 
matched the (G+C) content of the entire genome for both species (Figure 4.5B).  Therefore, 
these retroposed sequences and flanking repetitive elements are not preferentially located 
in (A+T) rich regions.     
 
Discussion 
We conducted a comprehensive analysis of the glycolytic pathway in the human and 
mouse genomes.  The mouse genome contains a larger number of retroposed sequences 
originating from the glycolytic enzymes when compared to the human genome.  There is 
frequent retrotransposition of orthologous genes encoding glycolytic enzymes in humans 
and mice.  The total number of retroposed sequences matching glycolytic enzymes in the 
human (94) and mouse (291) genomes is striking.  If the approximate 30,000 protein coding 
genes in the mouse and human genome contained the same number of matching 
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retroposed sequences as the 25 intron-containing genes in the glycolytic pathway, we would 
expect upwards of 270,000 total retroposed sequences [57].  In contrast, current estimates 
of the total retroposed sequence population is much lower, roughly 5000 in humans and 
8000 in mice [59, 60].  The striking number of retroposed sequences matching glycolytic 
enzymes is most likely due to gene expression in the male germline.       
Only retrotransposition events that occur in the germline are inherited and contribute 
to gene family expansion.  In order for retrotransposition events to be maintained in the 
genome they must occur in the germline.  Along with cellular localization, there are other 
characteristics that preferentially promote retrotransposition of certain mRNA transcripts, 
including stability of RNA in the cytoplasm where LINE ORF1 protein is shown to localize 
[61, 62].  In our study, we identified preferential retrotransposition of gene family members of 
the glycolytic enzymes expressed in the testis.  We found retrotransposition of Pgam1, not 
Pgam2, in the human and mouse genome.  Both Pgam1 and Pgam2 are expressed in the 
mouse testis, but Pgam1 is expressed in early spermatogenesis, while Pgam2 is expressed 
in haploid spermatogenic cells following meiosis [63, 64].  Eno1 is expressed in the mouse 
testis at 16-20 days post-natal, when spermatocytes are first expressed [65].  In mouse 
Pgk1 is expressed in spermatogonia and early spermatocytes, while Pgk2 expression is first 
detected in preleptotene spermatocytes [66].  In all three cases, the gene that is 
preferentially retroposed is the one expressed at early stages of spermatogenesis, when 
retrotransposition is thought to occur.  A recent study detected retrotransposition events 
during spermatogenesis, although the majority occurred during early stages of 
embryogenesis immediately following fertilization [67].  
Most retroposed sequences are pseudogenes.  On average, pseudogenes in the 
human genome are 86% identical at the nucleotide level to their parent gene [33], while 
pseudogenes in the mouse genome are 77% identical at the nucleotide level to their parent 
gene [59].  Pseudogenes matching the glycolytic enzymes are similar to the human average 
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in terms of nucleotide identity, ranging from 82-100% with an average of 89.2%.  However, 
retroposed sequences in mice have a greater nucleotide identity to their parent gene, also 
ranging from 82-100% with an average of 93.4%.  These values are much greater than the 
average values, again supporting recent divergence of retroposed sequences matching 
glycolytic enzymes.  The average level of sequence identity between the human and mouse 
genomes is 69.1% [57].  The related sequences matching glycolytic enzymes in the mouse 
and human genomes are greater than 80% identical to their parent gene, indicating that 
these retrotransposition events occurred independently following the divergence of primates 
and rodents. 
Greater than 45% of the human genome and 35% of the mouse genome is 
composed of repetitive elements [57, 68].  The amount of LINE and LTR repetitive elements 
was significantly higher flanking retroposed sequences when compared to intron-containing 
glycolytic enzymes.  SINE elements were equally abundant (Supplemental Figure 4.4) 
flanking both types of sequences and match the total percentage of SINE elements in the 
human (13.6%) and mouse (8.2%) genomes [57].  There are examples of LINE and LTR 
elements that are either primate or rodent specific [69].  Our study identified retroposed 
sequences that diverged following the primate/rodent split, which we would expect since 
retrotransposition is facilitated by repetitive elements.  The number of retroposed sequences 
combined with the nucleotide divergence of these sequences supports lineage-specific 
divergence of retroposed sequences.   
Recent evidence supports both repression of repetitive elements in male germ cells 
through methylation and small RNA pathways [70-72].  In most cases the insertion and 
deletion of genomic sequence that occurs in the germline is deleterious, but it some cases it 
can be advantageous.  Our study supports a role of retrotransposition in the germline for 
creating gene diversity.  A strict regulation of repetitive element expression is achieved 
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through multiple mechanisms, in order to promote the generation of new genes with 
functional difference while also preserving existing genomic sequence.   
Genes with the most processed pseudogenes include housekeeping genes and 
metabolic enzymes, and both Ldha and Gapdh are among the most retroposed transcripts 
in the human genome [60, 73].  We excluded the glyceraldehyde-phosphate 
dehydrogenase (GAPDH) genes from this analysis due to the previous literature supporting 
the presence of at least 30 retroposed sequences matching GAPDH in human and over 400 
in mouse and rat [26, 57, 74]. It has been shown that the GAPDH retroposed sequences 
are located in heavily methylated and DNAse I-insensitive regions of the rat genome [75].  
Based upon sequence and phylogenetic analysis, it has been speculated that the GAPDH 
family arose through retrotransposition of retroposed sequences, suggesting transcription of 
retroposed sequences [74].      
The functional importance of our analysis was to identify retrogenes and/or novel 
sequence in parent genes that are expressed in the testis.  We found multiple retroposed 
genes with either evidence for maintained ORFs and/or alternative splice variants in the 
human and mouse genomes.  We identified five and seven retroposed sequences with 
ORFs in humans and mice, respectively.  We found two retroposed sequences in both the 
mouse and human genome supporting alternative splicing of the parent gene.  Retroposed 
sequences with ORFs and greater than 99% sequence identity to their parent gene resulted 
from recent retrotransposition events and were not analyzed for expression.  While we did 
not detect testis expression for any of the putative human retrogenes identified in this study, 
we cannot exclude the possibility that these genes are expressed in other tissues.  In fact, 
transcription of PGAM1-rs7 on the X chromosome has been confirmed in human leukocytes 
[39, 76].      
A Gpi1 retroposed sequence in the mouse genome gave evidence of an alternative 
splice variant of this gene, expressed in pachytene spermatocytes and round spermatids in 
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the mouse testis. Our data shows expression of Gpi1_v2 in spermatocytes, supporting the 
retrotransposition of this transcript during meiosis to create Gpi1-rs1.  Meiosis occurs in 
spermatocyte cells, and methylation of genomic DNA decreases specifically in leptotene and 
pachytene spermatocytes [77, 78]. DNA double strand breaks required for meiotic 
recombination are detected in leptotene spermatocytes [79], and LINE elements can take 
advantage of these naturally occurring double strand breaks.  There is evidence for the 
expression of the proteins encoded by LINE elements (ORF1 and ORF2) in leptotene and 
zygotene spermatocytes, which includes cells where prophase I of meiosis takes place [30].  
Our data shows expression of Gpi1_v2 in spermatocytes, supporting the retrotransposition 
of this transcript during meiosis to create Gpi1-rs1.  Taken together, it is clear that 
retrotransposition during meiosis can exploit both hypomethylation and double strand 
breaks.       
Our analysis confirmed that retroposed sequences are recent and lineage-specific, 
which supports the completion of similar genomic analyses in other organisms to confirm all 
genes encoding glycolytic enzymes.  We found frequent, lineage-specific retrotransposition 
of certain glycolytic enzymes in the human and mouse genomes.  Integration of 
retrotransposition events is random and LINE-1 and LTR dependent.  Some of these 
sequences support the expression of alternative splice variants.  Many of these retroposed 
sequences have maintained open reading frames.  While these sequences were not found 
to be expressed in the testis, the fact that they have open reading frames suggests 
functional importance of the proteins encoded by these genes.  In order for the coding 
sequence of these genes to be preserved, they should undergo positive selection, possibly 
in the context of reproductive fitness [47, 48].  In fact, multiple studies have confirmed 
misexpression of glycolytic enzymes (including Gpi1) in sperm from infertile patients [80, 
81].  Glycolysis is essential for sperm motility and fertilization, supporting the creation of new 
genes encoding glycolytic enzymes that promote reproductive success.      
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Figure 4.1 
 
 
 
 
Figure 4.1.  Gene and species-specific divergence of human and mouse retroposed 
sequences.  Retroposed sequences matching each enzyme are represented by a different 
color, as shown in the figure legend.  Genes are stacked in each bar as listed in figure 
legend.   
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Figure 4.2 
 
  126
Figure 4.2.  Retroposed sequences support the expression of novel transcripts.   
Gene structure of parents genes and newly identified retroposed sequences in the human 
and mouse genome with ORFs (red and yellow exons), upstream start codons (black 
exons), and/or alternatively spliced exons (diagonal lined boxes).  Within these gene 
structures, sequences containing LINE elements are denoted by horizontal lines. Coding 
regions for retroposed sequences with open reading frames were compared to their parent 
gene, and the percent identity at the nucleotide level is shown next to the corresponding 
gene structure.  
  127
Figure 4.3 
 
 
Figure 4.3.  Human open reading frames with divergent sequences are not expressed 
in testis.  (A)  Diagram of RT-PCR approach used to distinguish expression of transcripts.  
Black arrows denote primer sets used to amplify both parent gene and retroposed 
sequence.  Fraction next to retroposed sequence gene structure shows the number of 
unique nucleotide residues in the amplified product.  (B)  RT-PCR using primers that would 
amplify both the retroposed sequence and the parent glycolytic enzyme, followed by single-
strand conformation polymorphism (SSCP) gel electrophoresis confirmed the absence of 
TPI1-rs1, PGAM1- rs7, and ENO1- rs1 transcripts in pooled human testis RNA samples.  
PCR products amplified from human genomic DNA (G1 and G2; two individuals) show the 
expected position of transcripts from retroposed sequences.  PCR products amplified from 
pooled testis total RNA are located in lanes T1, T2, and T3 (triplicate cDNA preparations).  
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Figure 4.4 
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Figure 4.4.  Expression of an alternative Gpi1 transcript in mouse spermatogenic 
cells.  (A)  Diagram of RT-PCR approach used to distinguish expression of Gpi1-related 
transcripts.  Gray arrows denote primer set used to differentiate transcripts containing 
alternatively spliced exons 5 and 6 (boxes with diagonal lines).  Black arrows denote Gpi1-
rs1-specific primer set.   (B) Transcripts from Gpi1 were detected in all mouse tissues and 
isolated testicular cells. Gpi1-rs1 was amplified from genomic DNA to identify the expected 
size of PCR products from Gpi1 transcripts not containing exons 5 and 6. A product of the 
same size was detected in isolated pachytene spermatocytes (PS) and round spermatids 
(RS), but not condensing spermatids (CS).  This PCR fragment appears to be derived from 
Gpi1_v2, since Gpi1_rs1-specific primers did not amplify a product.  (C)  A smaller GPI1_V2 
protein was not detected by western analysis using a polyclonal antibody raised against 
human GPI1.  A larger protein product was seen in isolated testicular cell, but not in mouse 
or human sperm. 
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Figure 4.5 
 
 
 
Figure 4.5.  Abundance of repetitive elements flanking retroposed sequences and 
(G+C) content.  (A) Analysis confirmed a significant different in LINE and LTR, but not SINE 
elements within 1 kb flanking either retroposed sequences or genes encoding the glycolytic 
enzymes.  Position of LINE and LTR elements flanking retroposed sequences (grey) or 
genes encoding all glycolytic enzymes (black).  (B)  (G+C) content (%) of 10kb sequence 
flanking human (grey) and mouse (black) retroposed sequences.  Pooled upstream and 
downstream flanking sequences.     
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Table 4.1.  Gene families encoding glycolytic enzymes and the parent genes that are 
retroposed.  Number next to “Yes” in retroposed sequence column represents the total 
number of retroposed sequences matching the parent gene.   “Ret. seq.” refers to 
retroposed sequence.  Total number of retroposed sequences matching glycolytic enzymes 
is 94 in the human genome and 291 in the mouse genome. 
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Supplemental Figure 4.1 
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Supplemental Figure 4.1.  Amino acid alignment of retroposed sequences in the 
human genome with maintained open reading frames.   Asterisks (*) denote identical 
residues. Methionine residues are highlighted in grey boxes, residues marked as “X” in a 
black box denote stop codons, and dashes denote deleted codons.  
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Supplemental Figure 4.2 
 
 
 
 
 
 
Supplemental Figure 4.2.  Amino acid alignments are shown for retroposed 
sequences containing upstream start codons. (A) Amino acid sequence alignment 
comparing upstream extensions of human retroposed sequences to the parent glycolytic 
enzymes.  (B)  Amino acid sequence alignment of mouse retroposed sequences with 
upstream start codons and the parent glycolytic enzymes.  Asterisks (*) denote identical 
residues.  Methionine residues are highlighted in grey boxes, residues marked as “X” in a 
black box denote stop codons, and dashes indicate deleted codon
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Supplemental Figure 4.3 
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Supplemental Figure 4.3.  Amino acid alignment of GPI1-related sequences in the 
mouse genome with maintained open reading frames (GPI1-rs1).  Asterisks (*) denote 
identical residues. Methionine residues are highlighted in grey boxes and dashes denote 
deleted codons.
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Supplemental Figure 4.4 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 4.4.  Percent frequency of repetitive elements flanking 
retroposed sequences and genes encoding glycolytic enzymes in the (A) human and 
(B) mouse genome.  Gray bars denote percent frequency of SINE, LINE and LTR elements 
both upstream and downstream of retroposed sequences.  Black bars represent percent 
frequency of SINE, LINE and LTR elements flanking genes encoding all glycolytic enzymes.   
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Supplemental Table 4.1. Human retroposed sequences matching genes encoding 
glycolytic enzymes 
Parent Gene Gene name Chr Start End Strand FL CDS 
HK2 HK2-rs1 X 79711597 79717193 - Y 
GPI1 GPI1-rs1 3 53014814 53015169 -  
ALDOA ALDOA-rs1 10 127345239 127346612 - Y 
 ALDOA-rs2 3 52202205 52204044 +  
TPI1 TPI1-rs1 1 76938028 76939260 + Y 
 TPI1-rs2 7 128483271 128484502 + Y 
 TPI1-rs3 4 48713051 48713961 - Y 
 TPI1-rs4 6 116466583 116467789 + Y 
PGK1 PGK1-rs1 X 67206648 67208343 - Y 
 PGK1-rs2 19 12531320 12533092 - Y 
PGAM1 PGAM1-rs1 12 102948637 102950343 + Y 
 PGAM1-rs2 15 94784888 94786599 - Y 
 PGAM1-rs3 3 9365078 9366726 - Y 
 PGAM1-rs4 12 92557837 92559523 - Y 
 PGAM1-rs5 12 94590196 94591866 + Y 
 PGAM1-rs6 6 73821525 73823177 + Y 
 PGAM1-rs7 X 77110148 77111803 - Y 
 PGAM1-rs8 11 91738423 91740066 - Y 
 PGAM1-rs9 X 46390044 46391709 -  
 PGAM1-rs10 9 35932321 35933832 -  
 PGAM1-rs11 20 11549802 11551012 +  
 PGAM1-rs12 X 54715275 54717274 +  
 PGAM1-rs13 11 64698204 64699538 -  
 PGAM1-rs14 4 116903998 116905323 -  
 PGAM1-rs15 13 59794725 59795890 +  
 PGAM1-rs16 12 46570073 46570979 - UTR 
 PGAM1-rs17 2 23948642 23949404 -  
 PGAM1-rs18 1 10041994 10042676 +  
 PGAM1-rs19 5 57492909 57493336 +  
 PGAM1-rs20 8 108728816 108729137 +  
 PGAM1-rs21 7 7410252 7410423 - UTR 
ENO1 ENO1-rs1 1 234713027 234714826 + Y 
 ENO1-rs2 15 90765047 90765198 -  
 ENO1-rs3 15 90766554 90766652 -  
 ENO1-rs4 9 22053949 22054012 - UTR 
PKM2 PKM2-rs1 1 114880051 114882605 + Y 
 PKM2-rs2 6 5917597 5919858 + Y 
 PKM2-rs3 X 65634319 65636611 + Y 
 PKM2-rs4 8 76451507 76452423 -  
 PKM2-rs5 5 8779377 8780055 +  
 PKM2-rs6 6 86426308 86426934 -  
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Supplemental Table 1.  Human retroposed sequences matching genes encoding 
glycolytic enzymes.  Gene name given to each retroposed sequence in the human 
genome, along with the chromosome position and strand.  FL CDS refers to those 
sequences containing full length coding sequence (Y) or only untranslated sequence (UTR), 
regardless of if sequences are in frame.  In some cases, more than one parent gene and/or 
retroposed sequence is located at the same chromosome position.  This includes:  7:44 is 
GCK and PGAM2; 10:71 is HK1 and HKDC1; 10:99 is PGAM1, PGAM1-rs16, PGAM1-rs20, 
and PGAM1-rs23; 12:7 is TPI1, GAPDH, and ENO2; 15:91 is ENO1-rs2 and ENO1-rs3; 
X:66 is PKM2-rs3 and PKM2-rs7  
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Supplemental Table 4.2. Mouse retroposed sequences matching genes 
encoding glycolytic enzymes 
Parent Gene Gene name Chr Start End Strand FL CDS 
Hk1 Hk1-rs1 18 29504342 29504735 + UTR 
Gpi1 Gpi1-rs1 8 52202205 52204044 + Y 
Tpi1 Tpi1-rs1 14 17779166 17780521 + Y 
 Tpi1-rs2 10 44309731 44312928 +  
 Tpi1-rs3 9 31755930 31757215 + Y 
 Tpi1-rs4 18 20706529 20707859 - Y 
 Tpi1-rs5 10 18821352 18822679 + Y 
 Tpi1-rs6 3 65932328 65933674 - Y 
 Tpi1-rs7 13 25547615 25548396 +  
 Tpi1-rs8 5 83621602 83622074 - UTR 
 Tpi1-rs9 2 9191857 9192103 -  
 Tpi1-rs10 7 54502936 54503214 + UTR 
 Tpi1-rs11 7 54777639 54777893 + UTR 
 Tpi1-rs12 7 55039236 55039446 + UTR 
 Tpi1-rs13 7 54608077 54608280 + UTR 
 Tpi1-rs14 7 55246555 55246649 + UTR 
 Tpi1-rs15 7 54503234 54503328 + UTR 
Pgk1 Pgk1-rs1 12 10905372 10907119 - Y 
 Pgk1-rs2 3 57906493 57908218 - Y 
 Pgk1-rs3 6 29911075 29912501 +  
 Pgk1-rs4 3 18464493 18465979 + Y 
 Pgk1-rs5 5 85295224 85295820 -  
 Pgk1-rs6 18 6760085 6760954 -  
 Pgk1-rs7 12 94954868 94955589 -  
 Pgk1-rs8 16 81909252 81909959 +  
 Pgk1-rs9 5 85290883 85291246 - UTR 
 Pgk1-rs10 14 86629605 86629757 + UTR 
 Pgk1-rs11 14 86629502 86629607 -  
Pgam1 Pgam1-rs1 7 28253905 28255638 - Y 
 Pgam1-rs2 11 21582397 21584105 - Y 
 Pgam1-rs3 3 11013514 11015192 - Y 
 Pgam1-rs4 11 79710680 79712360 + Y 
 Pgam1-rs5 18 80359524 80361179 +  
 Pgam1-rs6 15 59760341 59761759 -  
 Pgam1-rs7 9 50023246 50024730 +  
 Pgam1-rs8 1 9429117 9430492 +  
 Pgam1-rs9 X 136493319 136494149 + UTR 
 Pgam1-rs10 15 24059372 24059829 -  
 Pgam1-rs11 1 23984587 23984906 -  
 Pgam1-rs12 9 123442121 123442509 + UTR 
Pgam5 Pgam5-rs1 12 92720490 92723471 + Y 
Eno1 Eno1-rs1 18 48206301 48208032 + Y 
 Eno1-rs2 14 15279830 15281567 - Y 
 Eno1-rs3 3 130631969 130633696 - Y 
 Eno1-rs4 17 16918472 16920172 + Y 
 Eno1-rs5 13 88686724 88688161 + Y 
 Eno1-rs6 18 48227671 48229782 - Y 
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 Eno1-rs7 2 80677252 80678919 + Y 
 Eno1-rs8 X 126935186 126936782 - Y 
 Eno1-rs9 1 43842756 43844341 +  
 Eno1-rs10 2 100247310 100248846 - Y 
 Eno1-rs11 17 91191800 91193200 -  
 Eno1-rs12 4 64517715 64519081 -  
 Eno1-rs13 X 104474124 104475051 -  
 Eno1-rs14 10 18981708 18982788 +  
 Eno1-rs15 3 60573575 60574378 -  
 Eno1-rs16 10 68153941 68154564 +  
 Eno1-rs17 7 4902248 4902901 -  
 Eno1-rs18 2 83378374 83378827 -  
 Eno1-rs19 12 64765950 64766281 +  
 Eno1-rs20 1 165944207 165944509 - UTR 
 Eno1-rs21 1 193075309 193075608 +  
 Eno1-rs22 8 51205678 51205966 - UTR 
 Eno1-rs23 3 60574381 60574576 +  
 Eno1-rs24 14 53128289 53128461 -  
 Eno1-rs25 10 10895171 10895287 - UTR 
 Eno1-rs26 3 13489047 13489153 + UTR 
 Eno1-rs27 16 82107093 82107155 -  
Pkm2 Pkm2-rs1 12 31702976 31705204 + Y 
 Pkm2-rs2 2 100299806 100301960 - Y 
 Pkm2-rs3 2 100466315 100468469 - Y 
 Pkm2-rs4 9 97108961 97111315 - Y 
 Pkm2-rs5 X 111135597 111137719 + Y 
 Pkm2-rs6 X 8499059 8501032 -  
 Pkm2-rs7 5 22230028 22232077 - Y 
 Pkm2-rs8 15 69893125 69895146 - Y 
 Pkm2-rs9 18 21650759 21652605 - Y 
 Pkm2-rs10 13 13987730 13988873 -  
 Pkm2-rs11 X 159282193 159283455 -  
 Pkm2-rs12 12 88056199 88056992 +  
 Pkm2-rs13 17 93117277 93118318 -  
 Pkm2-rs14 3 43567795 43568688 -  
 Pkm2-rs15 16 54827438 54827861 -  
 Pkm2-rs16 13 14002561 14002728 -  
 Pkm2-rs17 19 54333380 54333485 - UTR 
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Supplemental Table 4.2.  Mouse retroposed sequences matching genes encoding 
glycolytic enzymes.   Gene name given to each retroposed sequence in the mouse 
genome, along with the chromosome position and strand.  FL CDS refers to those 
sequences containing full length coding sequence (Y) or only untranslated sequence (UTR), 
regardless of if sequences are in frame.  In some cases, more than one parent gene and/or 
retroposed sequence is located at the same chromosome position.  This includes:  2:100 is 
Eno1-rs10, Pkm2-rs2, Pkm2-rs3; 3:61 is Eno1-rs15, Eno1-rs23; 5:85 is Pgk1-rs5 and Pgk1-
rs9; 6:125 Tpi1, Gapdh, Eno2; 7:55 is Tpi1-rs11, Tpi1-rs12, Tpi1-rs13, Tpi1-rs14, Tpi1-rs15, 
Tpi1-rs16; 10:14 is Tpi1-rs4 and Eno1-rs14; 10:44 is Tpi1-rs7 and Tpi1-rs8; 11:6 is Gck and 
Pgam2; 13:14 is Pkm2-rs9 and Pkm2-rs17; 14:87 is Pgk1-rs10 and Pgk1-rs11; 16:82 is 
Pgk1-rs8 and Eno1-rs27; 18:48 is Eno1-rs1 and Eno1-rs6.    
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Overview 
         Gene targeting studies in the mouse demonstrate that glycolysis is required for 
sperm motility and male fertility [1].  While the glycolytic pathway is highly conserved, it is 
modified during spermatogenesis through the expression of novel isozymes derived from 
distinct genes or alternative splicing [2-7].  Genes with restricted expression in the male 
germline were generated by either gene duplication, as in Gapdhs, or retrotransposition, as 
in Pgk2, Aldoart1, and Aldoart2 [2, 3, 6, 8].   
Retrotransposition events which occur in the germline are carried on to future 
generations, accumulate in the genome, and can create new genes.  Retrogenes expressed 
in the germ cells are acted upon by selective pressure in the context of reproductive fitness.  
Retrotransposition has created multiple testis-specific retrogenes, including at least three 
glycolytic enzymes:  Pgk2, Aldoart1, Aldoart2 [2, 3, 6].  The identification of Aldoart1 also 
provided evidence for an N-terminal extension encoded by a splice variant of Aldoa, 
Aldoa_v2.  Both ALDOA_V2 and GAPDHS contain N-terminal extensions when compared 
to their somatic counterpart and are expressed across mammalian species [6, 7].  There is 
evidence that these N-terminal extensions facilitate binding to the fibrous sheath, a 
cytoskeletal structure which defines the limits of the principal piece.  Many glycolytic 
enzymes are tightly bound to the fibrous sheath, including ALDOA, GAPDHS, LDHA, and 
PKM2 [9].  Other glycolytic enzymes, including HK1, ENO1, and LDHC, are also localized in 
the principal piece [4, 10-12].  Thus, glycolysis is compartmentalized in a distinct segment of 
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the sperm flagellum away from the middle piece where oxidative phosphorylation occurs in 
mitochondria.   
The studies presented in this dissertation detail the expression of three 
spermatogenic-cell specific aldolase A isozymes generated by retrotransposition and 
alternative splicing.  Two of the ALDOA-related proteins contain N-terminal extensions and 
are tightly bound to the fibrous sheath.  Analysis of tertiary structure and kinetic properties of 
the individual sperm ALDOA-related enzymes demonstrated a lack of tetramer formation 
and reduced activity when expressed in E. coli.  Since retrotransposition is responsible for 
the creation of at least three spermatogenic-cell specific glycolytic enzymes, we analyzed 
the remainder of the pathway in the mouse and human genomes for retroposed copies of 
genes encoding glycolytic enzymes.  We found frequent retrotransposition of orthologous 
genes in both species.  Analysis of these retroposed sequences demonstrated independent 
divergence in the human and mouse genomes and an abundance of flanking LINE and LTR 
elements, supporting the role of autonomous repetitive elements in the retrotransposition of 
processed mRNA transcripts.     
 
Kinetic analysis and targeted localization of novel spermatogenic-cell specific ALDOA 
isozymes 
Two aldolase isozymes, ALDOA_V2 and ALDOART1, contain N-terminal extensions, 
and ALDOA_V2 is conserved in primates and rodents.  Proteomic analysis demonstrated 
tight binding of both ALDOA_V2 and ALDOART1 to the fibrous sheath in mouse sperm, 
suggesting a role for the N-terminal extension in localization [6].  Most of the aldolase 
activity in mouse sperm is found in insoluble fractions following Triton-X-100 and ß-
mercaptoethanol extraction.  Since mouse sperm contain all three ALDOA-related proteins 
(ALDOART1, ALDOART2, and ALDOA_V2), measuring activity in whole lysates does not 
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distinguish the activities of individual isozymes.  It is particularly interesting to analyze the 
kinetic properties of ALDOA_V2 since this isozyme is conserved across species and is 
expressed in human sperm [6].   Recombinant forms of the sperm ALDOA isozymes 
expressed in E. coli do not form tetramers and activity is significantly reduced when 
compared to ALDOA.  
Most of the endogenous aldolase activity was found in the insoluble fraction.  Many 
proteins expressed in sperm, including endogenous ALDOA_V2 and ALDOART1, are highly 
insoluble.  The fibrous sheath itself is an insoluble structure resistant to urea extraction [9].  
However, recombinant forms of sperm ALDOA-related proteins are soluble when expressed 
in E. coli, providing evidence that insolubility of sperm ALDOA isozymes is due to fibrous 
sheath binding.   
Recombinant forms of the sperm ALDOA-related proteins did not form tetramers and 
had reduced activity compared to ALDOA, which may highlight distinctive properties of 
sperm enzymes which cannot be recapitulated in a bacterial expression system.  Class I 
ALDOA is expressed in all eukaryotes and some prokaryotes, but the sperm ALDOA-related 
proteins are expressed only in some mammals, including rodents and primates [6, 13].  
While we have utilized multiple E. coli host strains to attempt to promote expression of rare 
codons, it may be advantageous to design expression constructs using codon optimization 
to promote higher levels of expression, which has been successful with recombinant 
GAPDHS expression ([14] and P. Danshina, unpublished data).   Also, a mammalian 
expression system may help to facilitate tetramer formation of sperm ALDOA-related 
proteins.   
It is possible that the sperm aldolase isozymes require post-translational 
modifications and/or disulfide bond formation for proper folding, which can only be 
recapitulated in a mammalian expression system.  The fibrous sheath is stabilized by 
disulfide bonds, and disulfide bonds also form during sperm maturation in the epididymis 
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[15, 16].  While ALDOA does not require disulfide bonds for proper folding and tetramer 
formation, the sperm ALDOA-related proteins may need additional modifications to promote 
proper folding, tetramer formation and subsequent activity.   
Expression of sperm ALDOA-related proteins in E. coli produced slightly lower yields 
than ALDOA, and we have yet to confirm by circular dichroism if these proteins are properly 
folded.  Therefore, it is also possible that folding difficulties contributed to reduced activity of 
sperm ALDOA-related proteins.  If we can overcome experimental difficulties with protein 
expression, measuring the kinetic properties of recombinant sperm ALDOA-related proteins 
would allow us to determine whether each isozyme possesses distinct catalytic functions.  
Amino acid alignment [6] and modeling data suggests that ALDOART1 and ALDOART2 
may have ALDOB-like function, so it would be advantageous to measure both glycolytic 
(with fructose-1,6-bisphosphate as a substrate) and fructolytic (with fructose-1-phosphate as 
a substrate) activity for these isozymes.      
Compartmentalization of glycolytic enzymes to the fibrous sheath may help to 
facilitate effective glycolytic ATP production in the flagellum.  It is possible that these 
enzymes form a complex which may help to “shuttle” substrates through the pathway in an 
efficient manner[17].  Several glycolytic enzymes are tethered to the fibrous sheath [9].  
Similar targeted localization of glycolytic enzymes is seen in human erythrocytes, another 
glycolysis-dependent cell type.  In the erythrocyte, GAPDH, ALDOA, PFK, and LDHA all 
bind directly to another protein, Band 3, which acts as a scaffold to form a glycolytic enzyme 
complex [18, 19].  In Drosophila both GAPDH and ALDOA are localized to the Z-discs and 
M-lines in flight muscles, again supporting localized ATP production in glycolysis-dependent 
fast moving muscles [20, 21].  Finally, ALDOA expressed in Trypanosome brucei  
possesses a ten residue N-terminal extension that is hypothesized to direct localization to 
the glycosome, an organelle containing the glycolytic enzymes [22].  In a similar fashion, the 
expression of novel ALDOA-related proteins with unique N-terminal extensions may direct 
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proper complex formation or localization of glycolytic enzymes to the principal piece of 
mammalian sperm, facilitating high levels of ATP production.    
Multiple glycolytic enzymes are tightly bound to the sperm fibrous sheath, including 
GAPDHS, ALDOA, LDHA, and PKM2 [9].  Immunoblot analysis indicates that the larger form 
of each variant is present in the fibrous sheath fraction following purification [9].  GAPDHS, 
ALDOA_V2 and ALDOART1 contain N-terminal extensions when compared to their somatic 
counterparts [6, 7].  We have also recently identified a splice variant of LDHA (LDHA_V2) 
which contains an N-terminal extension when compared to somatic LDHA.  Proteomic 
analysis confirmed tight binding of LDHA_V2 to the fibrous sheath in mouse sperm.  
Evidence for an N-terminal extension of PKM2 in boar sperm also supports modification of 
this enzyme to promote tight binding to the fibrous sheath [23, 24].  The genomic location of 
sequence encoding the entire N-terminal extension has not been identified.  However, a 
larger PKM2 immunoreactive band is found in the final fibrous sheath fraction, suggesting 
tight binding of this enzyme via an N-terminal extension [9].  These studies suggest that N-
terminal extensions may promote tight binding of several glycolytic enzymes to the fibrous 
sheath for localized ATP production along the sperm flagellum. 
Our lab is currently using transgenic and knockout mice to address the role of N-
terminal extensions in tight binding to the fibrous sheath.  GAPDHS demonstrates restricted 
localization to the principal piece [25].  Transgenic mice containing FLAG-tagged GAPDHS 
with and without the N-terminal extension have been generated and crossed to mice lacking 
the Gapdhs gene (Z. Huang, unpublished data).  Only transgenic GAPDHS with the N-
terminal extension was localized exclusively in the principal piece, supporting an essential 
role of the N-terminal extension in correct targeting of this isozyme.    
If the N-terminal extensions in ALDOA_V2 and ALDOART1 also promote restricted 
expression to the principal piece and tight binding to the fibrous sheath, this conserved 
function would be an example of convergent evolution.  Using a similar transgenic/knockout 
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approach (as with GAPDHS) to address the role of the N-terminal extension in ALDOA_V2 
and ALDOART1 would be extremely difficult, since at least three endogenous ALDOA 
isoforms are expressed in sperm [6].  Targeted gene disruption of the individual sperm 
ALDOA isozymes would likely have no phenotype due to functional redundancy, and would 
require a triple knockout of all three variants.  While it would be possible to disrupt both the 
ALDOART1 and ALDOART2 genes, targeted disruption of the exon encoding the 
alternatively spliced exon of ALDOA_V2 could be more difficult.   
To look for protein-protein interactions and complex formation, we can purify 
endogenous sperm ALDOA-related proteins in soluble fractions from testis lysates 
combined with gel filtration chromatography.  Preliminary data from this approach 
demonstrated co-fractionation of the larger immunoreactive ALDOA-related band, containing 
ALDOA_V2 and ALDOART1, with GAPDHS (K. Miki, unpublished data).  This data suggests 
that glycolytic enzymes tightly bound to the fibrous sheath directly interact or form a 
complex, possibly via N-terminal extensions.  GST pull down assays using both testicular 
and sperm lysates did not confirm a direct interaction between any of the sperm ALDOA-
related proteins and GAPDHS or AKAP4, both abundant proteins of the fibrous sheath (data 
not shown).   
 
Retrotransposition creates genes with novel functions implicated in reproductive 
fitness    
         Comparative genomics and expression analysis of genes encoding the glycolytic 
enzymes supports retrotransposition as a mechanism to create new genes with novel 
functions.  Retrotransposition events are only transmitted when they occur in the germline.   
If new genes generated by retrotransposition are expressed in the germline, they undergo 
selective pressure in the germline.  Expression of genes in spermatogenic cells can have a 
direct effect reproductive fitness, in the context of proper spermatogenesis and male 
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fertility.  In fact, genes that are involved in reproduction and spermatogenesis are under 
strong positive selection and include some the most rapidly evolving genes across multiple 
species [26-28].     
When analyzing a particular gene of interest at the molecular level it is extremely 
important to identify all genes expressed, keeping in mind the possible redundant function of 
multiple expressed isoforms.  Previously identified testis-specific retrogenes include Pgk2, 
Aldoart1, and Aldoart2 [2, 3, 6].  In our study we detected expression of an alternative Gpi1 
transcript in mouse spermatogenic cells.  It is possible that the remaining newly identified 
retroposed sequences may be expressed in other tissues, as with PGAM1-rs7 which is 
transcribed in human leukocytes.  In particular, cells and tissues that preferentially depend 
upon glycolysis for ATP may benefit from modification of the glycolytic pathway, such as 
mitochondria-deficient red blood cells and fast skeletal muscle fibers [29, 30].  Performing a 
similar genomic and expression analysis for genes in other pathways modified during 
spermatogenesis, such as oxidative phosphorylation or tyrosine phosphorylation, may 
detect expression of additional novel genes.  Our analysis confirmed recent, independent 
divergence of retroposed sequences in the human and mouse genomes.  Lineage-specific 
retrotransposition events suggest that similar genomic analysis in other species would be 
useful to identify all expressed genes and conserved, functionally important glycolytic 
enzyme variants.   
Only certain genes in the glycolytic pathway are retroposed, and there is preliminary 
data supporting expression of these genes in testicular germ cells.  Identification of the cell 
types where the parent genes are expressed during spermatogenesis may help to pinpoint 
the spermatogenic cell type where retrotransposition occurs.  Retrotransposition that occurs 
during meiosis can take advantage of double strand breaks, chromatin remodeling, and 
reduced DNA methylation [31].  In fact, the open reading frames expressed from LINE 
elements are expressed during meiosis in spermatocytes [32].  A recent study demonstrated 
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active retrotransposition of human and mouse LINE elements during spermatogenesis, 
however the majority of these events occurred following fertilization in early stages of 
embryogenesis [33]. 
A more detailed understanding of sperm metabolism and its regulation has potential 
clinical implications, particularly for assessing potential causes of male infertility.  It is likely 
that disruptive mutations in genes that encode sperm glycolytic enzymes would impair 
energy production and sperm motility.  Each step of the glycolytic pathway is catalyzed by 
multiple isozymes which complicates the genetic analysis for genes contributing to male 
infertility.  Annotation of all genes, retrogenes and pseudogenes matching glycolytic 
enzymes will facilitate targeted sequencing of human genes encoding glycolytic enzymes in 
patients with male factor infertility.  Identification of candidate mutations in these genes 
would provide insights into the genetic basis of some cases of male infertility.   
Enzymes are excellent pharmaceutical targets, since binding of an inhibitor molecule 
into the active can has the ability to selectively block enzyme activity.  Sperm-specific 
glycolytic enzymes are novel contraceptive targets that could possibly be selectively 
inhibited to impair sperm ATP production and motility.  GAPDHS is an example of one 
candidate contraceptive target.  Early studies developing reversible contraceptives identified 
chlorinated compounds as inhibitors of GAPDHS, resulting in reduced glycolytic activity and 
motility [34].  In addition, targeted gene disruption of the Gapdhs gene resulted in 
dramatically reduced sperm motility associate with male infertility [1].  GAPDHS has unique 
kinetic properties when compared to GAPDH and can therefore be selectively inhibited (P. 
Danshina, unpublished data).   
ALDOA_V2 is the only sperm ALDOA-related protein expressed in human sperm.  
The only difference between ALDOA_V2 and ALDOA is the N-terminal extension, so it is 
unlikely that ALDOA_V2 could be specifically inhibited without blocking the ubiquitously 
expressed ALDOA.  However, completion of the kinetic analysis of ALDOA_V2 will help to 
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determine if this enzyme has distinct catalytic properties that can be selectively inhibited.  
Taken together, understanding the role of glycolytic isozymes in sperm energy metabolism 
will allow for the rational design of targeted contraceptive strategies and may open new 
avenues for the treatment of infertility.  
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